1
|
Sweeny L, Long SM, Pipkorn P, Wax MK, Thomas CM, Curry JM, Yang S, Lander D, Chowdhury F, Amin D, Kane AC, Miles BA, Salama A, Cannady SB, Tasche K, Mann D, Jackson R. Microvascular reconstruction of medication related osteonecrosis of the head and neck. Head Neck 2024. [PMID: 38294050 DOI: 10.1002/hed.27653] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/09/2023] [Revised: 01/04/2024] [Accepted: 01/13/2024] [Indexed: 02/01/2024] Open
Abstract
BACKGROUND Medication related osteonecrosis of the jaw (MRONJ) requiring free flap (FF) reconstruction is uncommon with limited reported findings. METHODS Multicenter, retrospective case series of 49 consecutive adult patients presenting with advanced MRONJ requiring FF reconstruction from 2010 to 2022. Perioperative complications and outcomes were analyzed. RESULTS Eighty-two percent (n = 40) of cases were of the mandible and 18% (n = 9) were of the maxilla. The mean follow-up was 15 months (±19.6). The majority of FF survived (96%, n = 47). FF reconstructions of the maxilla were more likely to require postoperative debridement (56%, 95% CI [27, 81%] vs. 15%, 95% CI [7, 25%], p = 0.008) or develop intraoral bone exposure (56%, 95% CI [27, 81%] vs. 18%, 95% CI [9, 27%], p = 0.02). Most patients (71%, n = 35) received preoperative antibiotics which was associated with a higher rate of FF survival (100% vs. 86%, 95% CI [60, 96%], p = 0.02) and fewer complications. CONCLUSIONS Patients undergoing FF reconstruction for MRONJ do well with high rates of FF success. MRONJ of the maxilla have a higher rate of some complications. Preoperative antibiotics correlated with higher FF survival and fewer postoperative complications.
Collapse
Affiliation(s)
- Larissa Sweeny
- Department of Otolaryngology-Head and Neck Surgery, University of Miami, Miami, Florida, USA
- Surgical Care Division, Miami Veterans Affairs Health Care System, Miami, Florida, USA
| | - Sallie M Long
- Department of Otolaryngology-Head and Neck Surgery, University of Miami, Miami, Florida, USA
| | - Patrik Pipkorn
- Department of Otolaryngology-Head and Neck Surgery, Washington University in St. Louis, Missouri, USA
| | - Mark K Wax
- Oregon Health and Science University School of Medicine, Oregon, Portland, USA
| | - Carissa M Thomas
- Department of Otolaryngology-Head and Neck Surgery, University of Alabama at Birmingham, Birmingham, Alabama, USA
| | - Joseph M Curry
- Department of Otolaryngology-Head and Neck Surgery, Thomas Jefferson University, Philadelphia, Pennsylvania, USA
| | - Sara Yang
- Oregon Health and Science University School of Medicine, Oregon, Portland, USA
| | - Daniel Lander
- Department of Otolaryngology-Head and Neck Surgery, Washington University in St. Louis, Missouri, USA
| | - Farshad Chowdhury
- Department of Otolaryngology-Head and Neck Surgery, University of Alabama at Birmingham, Birmingham, Alabama, USA
| | - Dev Amin
- Department of Otolaryngology-Head and Neck Surgery, Thomas Jefferson University, Philadelphia, Pennsylvania, USA
| | - Anne C Kane
- Department of Otolaryngology, University of Mississippi, Jackson, Mississippi, USA
| | - Brett A Miles
- Department Otolaryngology Head and Neck Oncology, Northwell Health System, New York, New York, USA
| | - Andrew Salama
- Division Oral and Maxillofacial Surgery, Northwell Health System, New York, New York, USA
| | - Steven B Cannady
- Department of Otolaryngology-Head and Neck Surgery, University of Pennsylvania Health System, Philadelphia, Pennsylvania, USA
| | - Kendall Tasche
- Department of Otolaryngology-Head and Neck Surgery, University of Pennsylvania Health System, Philadelphia, Pennsylvania, USA
| | - Derek Mann
- Department of Otolaryngology-Head and Neck Surgery, Thomas Jefferson University, Philadelphia, Pennsylvania, USA
| | - Ryan Jackson
- Department of Otolaryngology-Head and Neck Surgery, Washington University in St. Louis, Missouri, USA
| |
Collapse
|
2
|
Omole D, Khatib B, Patel AA, Cheng A, Salama A, Brecht LE, Hirsch DL. Reconstructing the Mandible: Jaw-In-A-Day: Where We Were, Where We Are, and the Future. Atlas Oral Maxillofac Surg Clin North Am 2023; 31:153-164. [PMID: 37500199 DOI: 10.1016/j.cxom.2023.04.010] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 07/29/2023]
Affiliation(s)
- David Omole
- Division of Oral and Maxillofacial Surgery, Department of Dental Medicine, Northwell Health, Long Island Jewish Medical Center, 270-05 76th Avenue, New Hyde Park, NY 11040, USA.
| | - Baber Khatib
- Providence Oral, Head and Neck Cancer Program and Clinic, Providence Cancer Center, Portland, OR, USA; Trauma Service, Legacy Emanuel Medical Center, Portland, OR, USA; Head and Neck Institute, 1849 NW Kearney Street #300, Portland, OR 97209, USA
| | - Ashish A Patel
- Providence Oral, Head and Neck Cancer Program and Clinic, Providence Cancer Center, Portland, OR, USA; Trauma Service, Legacy Emanuel Medical Center, Portland, OR, USA; Head and Neck Institute, 1849 NW Kearney Street #300, Portland, OR 97209, USA
| | - Allen Cheng
- Providence Oral, Head and Neck Cancer Program and Clinic, Providence Cancer Center, Portland, OR, USA; Trauma Service, Legacy Emanuel Medical Center, Portland, OR, USA; Head and Neck Institute, 1849 NW Kearney Street #300, Portland, OR 97209, USA
| | - Andrew Salama
- Division of Oral and Maxillofacial Surgery, Department of Dental Medicine, Northwell Health, Long Island Jewish Medical Center, 270-05 76th Avenue, New Hyde Park, NY 11040, USA
| | - Lawrence E Brecht
- Department of Dental Medicine, Northwell Health, Long Island Jewish Medical Center, 270-05 76th Avenue, New Hyde Park, NY 11040, USA
| | - David L Hirsch
- Division of Oral and Maxillofacial Surgery, Department of Dental Medicine, Northwell Health, Long Island Jewish Medical Center, 270-05 76th Avenue, New Hyde Park, NY 11040, USA
| |
Collapse
|
3
|
Dang RR, Kim J, Qureshi MM, Fazeli SR, Zhao Q, Noonan VL, Sundararajan D, Salama A, Truong MT. Impact of depth of invasion on local recurrence in R0 resected node-negative oral tongue squamous cell carcinoma. Head Neck 2023; 45:561-566. [PMID: 36513522 DOI: 10.1002/hed.27264] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/07/2022] [Revised: 11/04/2022] [Accepted: 11/23/2022] [Indexed: 12/15/2022] Open
Abstract
BACKGROUND This study evaluates the impact of depth of invasion (DOI) on local recurrence (LR) in node-negative oral tongue squamous cell carcinoma (SCC). METHODS Fifty-one patients were retrospectively reviewed from an institutional database. Patients were evaluated for local control (LC). Cox-proportional hazards modeling was used to calculate hazard ratios. RESULTS There were 84.3% T1/2 and 15.7% T3/4 classification tumors. The 3-year overall survival rate was 97.9%. Local failure rate was 5.7% with a 3-year LC of 93.6%. On Univariate analysis, increased hazard of LR was noted with each unit increase in DOI (HR 1.40, 95% CI 1.07-1.83, p = 0.014). Age, sex, T classification, margins ≥5 mm, lymphovascular invasion (LVI) and perineural invasion (PNI), and adjuvant treatment were not associated with LR. On Multivariate analysis, adjusting for age and adjuvant treatment, results for DOI remained significant (aHR 1.46, 95% CI 1.08-1.98, p = 0.013). CONCLUSION On evaluation of our institutional dataset increasing DOI was associated with increased hazard of local recurrence with oral tongue SCC.
Collapse
Affiliation(s)
- Rushil R Dang
- Division of Maxillofacial Oncology and Reconstructive Surgery, Department of Oral and Maxillofacial Surgery, Boston Medical Center, Boston, Massachusetts, USA
| | - Jaegak Kim
- Department of Oral and Maxillofacial Surgery, Boston Medical Center, Boston, Massachusetts, USA
| | - Muhammad M Qureshi
- Department of Radiation Oncology, Boston Medical center, Boston, Massachusetts, USA
| | - Shoreh Roghayeh Fazeli
- Department of Pathology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA
| | - Qing Zhao
- Department of Anatomic Pathology, Boston Medical Center, Boston, Massachusetts, USA
| | - Vikki L Noonan
- Division of Oral and Maxillofacial Pathology, Boston University Henry M. Goldman School of Dental Medicine, Boston, Massachusetts, USA
| | - Devaki Sundararajan
- Division of Oral and Maxillofacial Pathology, Boston University Henry M. Goldman School of Dental Medicine, Boston, Massachusetts, USA
| | - Andrew Salama
- Department of Oral and Maxillofacial Surgery, Long Island Jewish Medical Center, New York, New York, USA
| | - Minh Tam Truong
- Department of Radiation Oncology, Boston University School of Medicine, Boston, Massachusetts, USA
| |
Collapse
|
4
|
Dang RR, Brar B, Pasco JM, Rebhun C, Sohn W, Salama A. Dental Practice Patterns for Oral Care in Medical Oncology Patients-a Survey-Based Assessment of Massachusetts Dentists. J Cancer Educ 2022; 37:555-560. [PMID: 32761443 DOI: 10.1007/s13187-020-01845-8] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/11/2023]
Abstract
Oral complications associated with cancer therapy lead to a significant deterioration of oral health and overall quality of life. The primary aim of this study was to assess dental practice patterns followed by dentists for oral care of medical oncology patients and to identify potential barriers to recommended care. A questionnaire-based survey was developed using the Qualtrics online platform. It was electronically distributed to all dentists within the Massachusetts Dental Society (MDS). Descriptive statistics were automatically computed by Qualtrics. A total of 363 responses (10.7%) were received. Dentists reported minimal correspondence from the oncology team during referrals. Most dentists communicate treatment recommendations to the oncology team with regard to extractions (74.6%), restorations (66.7%), periodontal health (68.8%), and other urgent needs (73.5%). Potential obstacles to providing care included insufficient time for dental care before start of therapy (61%), lack of patient education on oral complications associated with therapy (56%), and lack of dental insurance (31%). Only 50% of the dentists felt adequately trained to treat oncology patients, and 46% of dentists infrequently followed the recommendations set by the National Institute of Dental and Craniofacial research (NIDCR). The findings of this study indicate significant variability in the referral patterns and practice protocols for medically necessary oral care in oncology patients. The major barriers to following established guidelines for care may be attributed to the lack of correspondence between provider teams, inadequate training of professionals, and financial or insurance factors associated with increased cost of supportive care.
Collapse
Affiliation(s)
- Rushil R Dang
- Department of Oral and Maxillofacial Surgery, Boston University Henry M. Goldman School of Dentistry, 635 Albany St, Boston, MA, 02118, USA
| | - Branden Brar
- Department of Oral and Maxillofacial Surgery, Boston University Henry M. Goldman School of Dentistry, 635 Albany St, Boston, MA, 02118, USA
| | | | - Chad Rebhun
- Department of Oral and Maxillofacial Surgery, Boston University Henry M. Goldman School of Dentistry, 635 Albany St, Boston, MA, 02118, USA
| | - Woosung Sohn
- Population Oral Health, School of Dentistry, University of Sydney, Sydney, Australia
| | - Andrew Salama
- Department of Oral and Maxillofacial Surgery, Boston University Henry M. Goldman School of Dentistry, 635 Albany St, Boston, MA, 02118, USA.
| |
Collapse
|
5
|
Mohamed S, Attia A, Mahmoud T, Salama A. Assessment of the Protective Effect of the Humoral Immune Response against Major Moraxella catarrhalis Surface Antigens on Otitis Media Manifestation in Egyptian Children. Int J Infect Dis 2022. [DOI: 10.1016/j.ijid.2021.12.216] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022] Open
|
6
|
Khattab M, El-Sallak M, Morcos SM, Salama A. Heat transfer and pressure drop for air-water mixtures in an isoflux vertical annulus / Wärmeübertragung und Druckabfall für Strömungen von Luft-Wasser-Gemischen in einem vertikalen Ringraum. KERNTECHNIK 2021. [DOI: 10.1515/kern-1996-612-310] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
7
|
Abdelnour S, El-Saadony M, Saghir S, Abd El-Hack M, Al-shargi O, Al-Gabri N, Salama A. Mitigating negative impacts of heat stress in growing rabbits via dietary prodigiosin supplementation. Livest Sci 2020. [DOI: 10.1016/j.livsci.2020.104220] [Citation(s) in RCA: 29] [Impact Index Per Article: 7.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/27/2022]
|
8
|
Farber A, Hardouin S, Cheng TW, Siracuse JJ, Devaiah A, Jones DW, Salama A. Resection of an Internal Carotid Artery Aneurysm With Extreme Cranial Exposure Maneuvers. J Vasc Surg 2020. [DOI: 10.1016/j.jvs.2020.04.129] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
9
|
Hashemi S, Oda M, Onoue K, Basa K, Rubin SJ, Sakai O, Salama A, Ezzat WH. Determining the optimal osteotomy distance with the fibula free flap in mandibular reconstruction. Am J Otolaryngol 2020; 41:102436. [PMID: 32144022 DOI: 10.1016/j.amjoto.2020.102436] [Citation(s) in RCA: 12] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/09/2020] [Accepted: 02/15/2020] [Indexed: 12/21/2022]
Abstract
OBJECTIVE Fibula free tissue transfer is a common and reliable method for mandibular reconstruction. Functional outcomes from this procedure are dependent on the successful union of the osseous segments postoperatively. This study was conducted to define the maximum gap-size criteria for osseous union to occur at osteotomy sites in fibula free flap reconstruction of the mandible. STUDY DESIGN Retrospective chart review. SETTING Tertiary care academic center. SUBJECTS AND METHODS A retrospective chart review of computed tomography and medical records was conducted on patients who underwent fibula free flap surgery and had imaging of the mandible at <3 months and >6 months after surgery. Distances between osteotomies were measured and evaluated for interval healing. Secondary data included subject age, sex, smoking status, diabetes, number of osteotomies, complications, and adjuvant therapy. RESULTS Thirty-eight osteotomy sites were analyzed from thirteen subjects and a total of 190 measurements were made. The mean gap size at the first scan that demonstrated union by the second scan interval was 1.31 mm and mean gap size demonstrating non-union was 2.55 mm (p < 0.01). Complication rate, number of osetotomies, adjuvant therapy, or medical co-morbidities did not significantly affect rates of union. CONCLUSIONS In this study, osseous union was achieved with a mean osteotomy gap size of 1.31 mm. The data suggests that distances between ossesous segments >2 .55mm have a higher risk of non-union. We believe the information from this study will help augment current and future techniques in the field of mandible reconstruction.
Collapse
Affiliation(s)
- Sean Hashemi
- Division of Facial Plastic and Reconstructive Surgery, Boston Medical Center, Department of Otolaryngology-Head and Neck Surgery, Boston University School of Medicine, Boston, MA, USA
| | - Masafumi Oda
- Department of Radiology, Boston Medical Center, Boston University School of Medicine, Boston, MA, USA
| | - Keita Onoue
- Department of Radiology, Boston Medical Center, Boston University School of Medicine, Boston, MA, USA
| | - Krystyne Basa
- Division of Facial Plastic and Reconstructive Surgery, Boston Medical Center, Department of Otolaryngology-Head and Neck Surgery, Boston University School of Medicine, Boston, MA, USA
| | - Samuel J Rubin
- Division of Facial Plastic and Reconstructive Surgery, Boston Medical Center, Department of Otolaryngology-Head and Neck Surgery, Boston University School of Medicine, Boston, MA, USA
| | - Osamu Sakai
- Department of Radiology, Boston Medical Center, Boston University School of Medicine, Boston, MA, USA
| | - Andrew Salama
- Department of Oral & Maxillofacial Surgery, Boston Medical Center, Boston University School of Medicine, Boston, MA, USA
| | - Waleed H Ezzat
- Division of Facial Plastic and Reconstructive Surgery, Boston Medical Center, Department of Otolaryngology-Head and Neck Surgery, Boston University School of Medicine, Boston, MA, USA.
| |
Collapse
|
10
|
Rubin SJ, Saunders SS, Kuperstock J, Gadaleta D, Burke PA, Grillone G, Moses JM, Murphy JP, Rodriguez G, Salama A, Platt MP. Quality improvement in tracheostomy care: A multidisciplinary approach to standardizing tracheostomy care to reduce complications. Am J Otolaryngol 2020; 41:102376. [PMID: 31924414 DOI: 10.1016/j.amjoto.2019.102376] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/08/2019] [Accepted: 12/10/2019] [Indexed: 11/24/2022]
Abstract
PURPOSE Develop a model for quality improvement in tracheostomy care and decrease tracheostomy-related complications. METHODS This study was a prospective quality improvement project at an academic tertiary care hospital. A multidisciplinary team was assembled to create institutional guidelines for clinical care during the pre-operative, intra-operative, and post-operative periods. Baseline data was compiled by retrospective chart review of 160 patients, and prospective tracking of select points over 8 months in 73 patients allowed for analysis of complications and clinical parameters. RESULTS Implementation of a quality improvement team was successful in creating guidelines, setting baseline parameters, and tracking data with run charts. Comparison of pre- and post-guideline data showed a trend toward decreased rate of major complications from 4.38% to 2.74% (p = 0.096). Variables including time to tracheotomy for prolonged intubation, surgical technique, day of first tracheostomy tube change, and specialty performing surgery did not show increased risk of complications. There were increased tracheostomy-related complications in cold months (p = 0.04). CONCLUSIONS An interdisciplinary quality improvement team can improve tracheostomy care by identifying system factors, standardizing care among specialties, and providing continuous monitoring of select data points.
Collapse
|
11
|
Elborai Y, Elgammal A, Salama A, Fawzy M, El-Desouky ED, Attia I, Shalaby LM. Cyclooxygenase-2 expression as a prognostic factor in pediatric classical Hodgkin lymphoma. Clin Transl Oncol 2020; 22:1539-1547. [PMID: 31970686 DOI: 10.1007/s12094-020-02297-8] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/28/2019] [Accepted: 01/09/2020] [Indexed: 01/22/2023]
Abstract
PURPOSE Cyclooxygenase-2 (COX-2) is an inflammation-related enzyme that has been shown to have a role in tumor initiation, angiogenesis, and proliferation. It has been demonstrated that COX-2 expression is increased in many tumors and is a negative prognostic parameter. Our objective is to investigate the prognostic value of COX-2 expression in pediatric patients with classical Hodgkin lymphoma (CHL). METHODS This was a retrospective analysis in pediatric patients (n = 127) diagnosed with CHL and treated at the pediatric oncology department, National Cancer Institute, Cairo University, January 2005-June 2013. We correlated COX-2 immunostaining in Reed-Sternberg (RS) cells with clinical variables and outcome. RESULTS COX-2 was expressed on 38.6% of RS cells. The median follow-up time was 48.4 months (range 4-114 months). The 5-year OS and PFS, in COX-2(+ve) versus COX-2(-ve) was 85.3% versus 96.0% (p = 0.248) and 78.6% versus 84.3% (p = 0.354), respectively. A multivariate analysis showed that COX-2(+ve) was not significantly associated with the 5-year OS (HR = 2.9; 95% CI 0.7-12.4, p = 0.149) or with the 5-year PFS (HR = 1.4; 95% CI 0.6-3.2, p = 0.490). High-risk patients in the COX-2(+ve) group had a significantly lower 5-year OS (p = 0.021). The 5-year PFS was significantly lower in the COX-2(+ve) group with B symptoms (p = 0.023) and bulky disease (p = 0.028). Radiotherapy was given only to high-risk patients; survival was much better in radiation-treated children in both the Cox-2(+ve) and Cox-2(-ve) groups. The magnitude of the radiotherapy effect was also greater in the Cox-2(+ve) group, but this difference was not statistically significant. CONCLUSION COX-2 expression showed a tendency to be a poor prognostic factor, but it failed to provide meaningful independent information. Further larger studies are needed to investigate COX-2 as a prognostic factor and potential therapeutic target.
Collapse
Affiliation(s)
- Y Elborai
- Pediatric Oncology Department, National Cancer Institute (NCI), Cairo University, Fom El-khalig Square Kasr El-Aini St., Cairo, 11796, Egypt.
| | - A Elgammal
- Pediatric Oncology Department, National Cancer Institute (NCI), Cairo University, Fom El-khalig Square Kasr El-Aini St., Cairo, 11796, Egypt
| | - A Salama
- Pathology Department, National Cancer Institute (NCI), Cairo University, Cairo, Egypt
| | - M Fawzy
- Pediatric Oncology Department, National Cancer Institute (NCI), Cairo University, Fom El-khalig Square Kasr El-Aini St., Cairo, 11796, Egypt
| | - E D El-Desouky
- Biostatistics and Cancer Epidemiology Department, National Cancer Institute (NCI), Cairo University, Cairo, Egypt
| | - I Attia
- Pediatric Oncology Department, National Cancer Institute (NCI), Cairo University, Fom El-khalig Square Kasr El-Aini St., Cairo, 11796, Egypt
| | - L M Shalaby
- Pediatric Oncology Department, National Cancer Institute (NCI), Cairo University, Fom El-khalig Square Kasr El-Aini St., Cairo, 11796, Egypt
| |
Collapse
|
12
|
Ali AMF, Salama A, Abd El Aziz I, Kamal H. P211 Short term impact of hemodialysis on right ventricular systolic function and pulmonary artery pressure in patients with end stage renal disease. Eur Heart J Cardiovasc Imaging 2020; 21. [DOI: 10.1093/ehjci/jez319.079] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 09/02/2023] Open
Abstract
Abstract
Introduction
Chronic kidney disease (CKD) is associated with increased morbidity and mortality. Cardiovascular disease (CVD) is the most common complication and a chief cause of death in patients with end stage renal disease (ESRD) accounting for 45% to 50% of causes of death in ESRD patient. Pulmonary hypertension (PH) occurs frequently in patients with CKD. The role of hemodialysis in reducing pulmonary artery pressure (PAP) and improving RV systolic function in not properly studied.
Purpose
To evaluate the effect of hemodialysis on Right ventricular (RV) systolic function and Pulmonary artery pressures using echocardiography in newly diagnosed end stage renal disease patients and after three months of regular hemodialysis.
Patients and Methods
30 patients recently diagnosed to have ESRD were enrolled and were followed up after three months. Trans-thoracic echocardiography was done prior to the first dialysis session and after three months of regular hemodialysis to asses RV systolic function and PAP.
Results
There was a significant improvement of RV systolic function assessed by trans-annular plane systolic excursion (TAPSE)(mm)(pre dialysis 18.9 ± 3.76, post 21.56 ±3.51, p <0.01), fractional area change (FAC)(%)(pre dialysis 41.27 ± 8.9, post 47.5 ± 6.1, p < 0.01),tricuspid lateral annular systolic velocity (S’)(cm/s) (pre dialysis 12.3 ± 2.79, post 14.16 ± 2.3, p < 0.01),myocardial performance index (MPI)(pre dialysis 0.2 ± 0.1, post 0.1 ± 0.1, p < 0.01)and right ventricular outflow tract fractional shortening (RVOT-FS)(%)(pre dialysis 36.5 ± 9.5, post 39.3 ± 8.6, p < 0.01)post dialysis (P value <0.01). All parameters of assessing pulmonary artery pressures; systolic pulmonary artery pressure (PASP)(mmHg)(pre dialysis 48.03 ± 17.16, post 35.12 ± 14.73, p < 0.01), pulmonary diastolic artery pressure (PADP)(mmHg)(pre dialysis 24.05 ± 9.7, post 18.12 ± 9.64, p < 0.01), mean pulmonary artery pressure (MPAP)(mmHg) (pre dialysis 35.61 ± 15.07, post 25.8 ± 12.06, p < 0.01), pulmonary capillary wedge pressure (PCWP)((pre dialysis 23.28 ± 8.74, post 17.39 ± 5.87, p < 0.01) and pulmonary vascular resistance (PVR)(Wood unit)(pre dialysis 1.89 ± 0.57, post 1.43 ± 0.46, p < 0.01) improved significantly post dialysis (P value <0.01).There was a significant inverse correlation between the duration of renal impairment and the improvement in SPAP and PCWP after the initiation of dialysis (P values are 0.021 and 0.015, Correlation co-efficient -0.421, -0.441 respectively). The best cut-off value for weight reductionduring dialysis for prediction of improvement of SPAP is 2.75 Kg (AUC = 0.950, CI = 0.881-1.000, P value < 0.01).
Conclusions
The present study shows that significant improvement occurred in all RV systolic function parameters and all parameters of assessing pulmonary artery pressures post dialysis in patients recently diagnosed to have ESRD. RVOT FS is a reliable method for assessing RV function and it is significantly correlated only with TAPSE and FAC at the baseline before dialysis.
Collapse
Affiliation(s)
- A M F Ali
- Suez Canal University, Ismailia, Egypt
| | - A Salama
- Suez Canal University, Ismailia, Egypt
| | | | - H Kamal
- Suez Canal University, Ismailia, Egypt
| |
Collapse
|
13
|
Ata EB, Salama A, Zaghawa A, Ghazy AA, Elsify A, Nayel M, Hegazy Y, Abdel-Rahman EH, Warda S. Seroprevalence of equine herpes virus-1 in endemic area of Egypt with risk factors assessment. BJVM 2020. [DOI: 10.15547/bjvm.2168] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Although equine herpesvirus-1 (EHV-1) infection occurs throughout the world; causing various health problems within horse population such as respiratory disease, abortion and myeloencephalopathy, there is information shortage concerning the epidemiological situation of EHVs in Egypt. This paper is the first study of EHV-1 prevalence rate in Monufia province (as a model for other provinces). During 2015, two hundred and seventy serum samples from EHV non-vaccinated horses were randomly collected from 9 centres of Monufia province. The indirect ELISA was used to detect the prevalence rate of the disease while assessment of the associated risk factors was conducted using univariate and multivariate logistic regression models. The results showed that EHV-1 infection was widespread among horses at Monufia province (apparent prevalence rate 64% and true prevalence rate 28%) and posed risk for the health of other equines in the region. Results of risk factors identification showed that horses > 5 years of age were at significant risk of getting EHV-1 infection than < 1-year-old horses (OR: 5; P<0.02), while males were twice more prone than females of getting the EHV-1 infection (OR: 2 and P<0.03). There was a significant effect of different localities on the prevalence of EHV-1 infection. The obtained results could be extrapolated to the different districts and governorates of Egypt because of the similarity of the husbandry system of equines all over Egypt.
Collapse
|
14
|
Kotb H, El-Abd M, Salama A. Response of “White Robin” Peach Trees Cv. (Prunus persica L.) to Cultivation Under Plastic Covering Conditions and Foliar Application by Hydrogen Cyanamide and Garlic Extract. Journal of Plant Production 2019; 10:1187-1194. [DOI: 10.21608/jpp.2019.87395] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 09/02/2023]
|
15
|
Othman M, El-Zamik F, Hegazy M, Salama A. ISOLATION AND IDENTIFICATION OF EGYPTIAN STRAINS OF Serratia marcescens PRODUCING ANTIBACTERIAL AND ANTIOXIDANT PRODIGIOSIN PIGMENT. ACTA ACUST UNITED AC 2019. [DOI: 10.21608/zjar.2019.48175] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
16
|
Dang R, Qureshi M, Truong M, Caldroney S, Salama A. Tumor Stage Re-categorization and Survival in Patients with Node-Negative Tongue Cancer: Impact of the 8th Edition of the American Joint Committee on Cancer Classification. J Oral Maxillofac Surg 2019. [DOI: 10.1016/j.joms.2019.06.064] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
17
|
al atassi H, Salama A. Are You Gritty and Resilient Enough to Succeed? Grit and Resilience May Be Related Dental Students’ Academic Success during Training. J Oral Maxillofac Surg 2019. [DOI: 10.1016/j.joms.2019.06.129] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
18
|
Elmogy AA, Gibreel M, Elkafrawy F, Shaaban M, Khafagy RT, Nabil SH, Soliman A, Salama A, Tantawy S, Ismael A, Romeih S, Elmozy W, Labib DO. P385An unusual presentation of hypertrophic cardiomyopathy: case report. Eur Heart J Cardiovasc Imaging 2019. [DOI: 10.1093/ehjci/jez109.026] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Affiliation(s)
- A A Elmogy
- Aswan Heart Centre, Radiology department, Aswan, Egypt
| | - M Gibreel
- Aswan Heart Centre, Radiology department, Aswan, Egypt
| | - F Elkafrawy
- Aswan Heart Centre, Radiology department, Aswan, Egypt
| | - M Shaaban
- Aswan Heart Centre, Radiology department, Aswan, Egypt
| | - R T Khafagy
- Aswan Heart Centre, Radiology department, Aswan, Egypt
| | - S H Nabil
- Aswan Heart Centre, Radiology department, Aswan, Egypt
| | - A Soliman
- Aswan Heart Centre, Radiology department, Aswan, Egypt
| | - A Salama
- Aswan Heart Centre, Radiology department, Aswan, Egypt
| | - S Tantawy
- Aswan Heart Centre, Radiology department, Aswan, Egypt
| | - A Ismael
- Aswan Heart Centre, Radiology department, Aswan, Egypt
| | - S Romeih
- Aswan Heart Centre, Radiology department, Aswan, Egypt
| | - W Elmozy
- Aswan Heart Centre, Radiology department, Aswan, Egypt
| | - D O Labib
- Aswan Heart Centre, Radiology department, Aswan, Egypt
| |
Collapse
|
19
|
Salama A, Soliman A, Khafagy R, Elmogy AA, Nabil SH, Shaaban M, Gibreel M, Elkafrawy F, Tantawy S, Labib DO, Elmozy W, Romeih S. 225Neglected unrepaired TGA with VSD, does CMR has a role? Eur Heart J Cardiovasc Imaging 2019. [DOI: 10.1093/ehjci/jez107.005] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Affiliation(s)
- A Salama
- Aswan Heart Centre, Aswan, Egypt
| | | | | | | | | | | | | | | | | | | | - W Elmozy
- Aswan Heart Centre, Aswan, Egypt
| | - S Romeih
- Aswan Heart Centre, Aswan, Egypt
| |
Collapse
|
20
|
Soliman A, Elmozy W, Romeih S, Khafagy R, Elmogy A, Nabil SH, Shaaban M, Gibreel M, Salama A, Elkafrawy F. P574Diagnosis of uhl anomaly in infancy, role of CMR. Eur Heart J Cardiovasc Imaging 2019. [DOI: 10.1093/ehjci/jez108.011] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Affiliation(s)
| | - W Elmozy
- Aswan Heart Centre, Aswan, Egypt
| | - S Romeih
- Aswan Heart Centre, Aswan, Egypt
| | | | - A Elmogy
- Aswan Heart Centre, Aswan, Egypt
| | | | | | | | - A Salama
- Aswan Heart Centre, Aswan, Egypt
| | | |
Collapse
|
21
|
Tantawy S, Shaaban M, Elkafrawy F, Khafagy R, Elmogy A, Salama A, Gibreel M, Soliman A, Nabil SH, Kharabeesh A, Labib D, Romeih S, Elmozy W. P161Longitudinal RV and LV strain in pulmonary hypertension patients using CMR feature tracking. Eur Heart J Cardiovasc Imaging 2019. [DOI: 10.1093/ehjci/jez117.024] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Affiliation(s)
- S Tantawy
- Aswan Heart Centre, Radiology, Aswan, Egypt
| | - M Shaaban
- Aswan Heart Centre, Radiology, Aswan, Egypt
| | | | - R Khafagy
- Aswan Heart Centre, Radiology, Aswan, Egypt
| | - A Elmogy
- Aswan Heart Centre, Radiology, Aswan, Egypt
| | - A Salama
- Aswan Heart Centre, Radiology, Aswan, Egypt
| | - M Gibreel
- Aswan Heart Centre, Radiology, Aswan, Egypt
| | - A Soliman
- Aswan Heart Centre, Radiology, Aswan, Egypt
| | - S H Nabil
- Aswan Heart Centre, Radiology, Aswan, Egypt
| | | | - D Labib
- Aswan Heart Centre, Radiology, Aswan, Egypt
| | - S Romeih
- Aswan Heart Centre, Radiology, Aswan, Egypt
| | - W Elmozy
- Aswan Heart Centre, Radiology, Aswan, Egypt
| |
Collapse
|
22
|
Khafagy RT, Elmogy AA, Nabil SH, Soliman A, Shaaban M, Gibreel M, Salama A, Elkafrawy F, Tantawy S, Elnadi M, Labib DO, Elmozy W, Romeih S. P1094D CMR flow mapping and strain analysis of a muscular left ventricular diverticulum. Eur Heart J Cardiovasc Imaging 2019. [DOI: 10.1093/ehjci/jez110.008] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Affiliation(s)
| | - A A Elmogy
- Aswan Heart Centre, Radiology, Aswan, Egypt
| | - S H Nabil
- Aswan Heart Centre, Radiology, Aswan, Egypt
| | - A Soliman
- Aswan Heart Centre, Radiology, Aswan, Egypt
| | - M Shaaban
- Aswan Heart Centre, Radiology, Aswan, Egypt
| | - M Gibreel
- Aswan Heart Centre, Radiology, Aswan, Egypt
| | - A Salama
- Aswan Heart Centre, Radiology, Aswan, Egypt
| | | | - S Tantawy
- Aswan Heart Centre, Radiology, Aswan, Egypt
| | - M Elnadi
- Aswan Heart Centre, Radiology, Aswan, Egypt
| | - D O Labib
- Aswan Heart Centre, Radiology, Aswan, Egypt
| | - W Elmozy
- Aswan Heart Centre, Radiology, Aswan, Egypt
| | - S Romeih
- Aswan Heart Centre, Radiology, Aswan, Egypt
| |
Collapse
|
23
|
Shaaban M, Tantawy S, Elkafrawy F, Salama A, Gibreel M, Elmogy A, Khafagy R, Soliman A, Nabil SH, Kharabesh A, Romeih S, Labib D, Elmozy W. P609Feature tracking cardiac magnetic resonance as a prognostic tool in successfully revascularized patients with acute myocardial infarction. Eur Heart J Cardiovasc Imaging 2019. [DOI: 10.1093/ehjci/jez116.014] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Affiliation(s)
| | | | | | - A Salama
- Aswan Heart Centre, Aswan, Egypt
| | | | - A Elmogy
- Aswan Heart Centre, Aswan, Egypt
| | | | | | | | | | - S Romeih
- Aswan Heart Centre, Aswan, Egypt
| | - D Labib
- Aswan Heart Centre, Aswan, Egypt
| | - W Elmozy
- Aswan Heart Centre, Aswan, Egypt
| |
Collapse
|
24
|
Nabil SH, Elmogy AA, Khafagy RT, Elkafrawy F, Soliman A, Shaaban M, Gibreel M, Salama A, Labib DO, Elmozy W, Romeih S. P404Atrial mass: what is typical does not appear always typical. Eur Heart J Cardiovasc Imaging 2019. [DOI: 10.1093/ehjci/jez109.043] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Affiliation(s)
- S H Nabil
- Aswan Heart Center, Radiology department, Aswan, Egypt
| | - A A Elmogy
- Aswan Heart Center, Radiology department, Aswan, Egypt
| | - R T Khafagy
- Aswan Heart Center, Radiology department, Aswan, Egypt
| | - F Elkafrawy
- Aswan Heart Center, Radiology department, Aswan, Egypt
| | - A Soliman
- Aswan Heart Center, Radiology department, Aswan, Egypt
| | - M Shaaban
- Aswan Heart Center, Radiology department, Aswan, Egypt
| | - M Gibreel
- Aswan Heart Center, Radiology department, Aswan, Egypt
| | - A Salama
- Aswan Heart Center, Radiology department, Aswan, Egypt
| | - D O Labib
- Aswan Heart Center, Radiology department, Aswan, Egypt
| | - W Elmozy
- Aswan Heart Center, Radiology department, Aswan, Egypt
| | - S Romeih
- Aswan Heart Center, Radiology department, Aswan, Egypt
| |
Collapse
|
25
|
Fazeli SR, Giglou KR, Soliman ML, Ezzat WH, Salama A, Zhao Q. Calcifying Epithelial Odontogenic (Pindborg) Tumor in a Child: A Case Report and Literature Review. Head Neck Pathol 2019; 13:580-586. [PMID: 30771214 PMCID: PMC6853849 DOI: 10.1007/s12105-019-01009-1] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/20/2018] [Accepted: 01/06/2019] [Indexed: 12/01/2022]
Abstract
Calcifying epithelial odontogenic tumor (CEOT) is a rare neoplasm, which accounts for < 1% of all odontogenic tumors. CEOT occurs more frequently in adults with a peak incidence in the 5th decade of life and is extremely rare in the pediatric population. We present a case of a 13-year-old girl who was found to have a mandibular CEOT. We summarize the radiological features, pathological findings, clinical management and literature review focusing on this entity in children.
Collapse
Affiliation(s)
- Shoreh R. Fazeli
- Department of Pathology, Boston University, Boston Medical Center, Boston, MA USA
| | - Kamyar R. Giglou
- Department of Oral and Maxillofacial Surgery, Boston University, School of Dental Medicine, Boston, MA USA
| | - Mahmoud L. Soliman
- Department of Pathology, Boston University, Boston Medical Center, Boston, MA USA
| | - Waleed H. Ezzat
- Department of Otolaryngology-Head and Neck, Boston University, Boston Medical Center, Boston, MA USA
| | - Andrew Salama
- Department of Oral and Maxillofacial Surgery, Boston University, School of Dental Medicine, Boston, MA USA
| | - Qing Zhao
- Department of Pathology, Boston University, Boston Medical Center, Boston, MA USA
| |
Collapse
|
26
|
Arbach O, Taumberger AB, Wietek S, Cervinek L, Salama A. Efficacy and safety of a new intravenous immunoglobulin (Panzyga ® ) in chronic immune thrombocytopenia. Transfus Med 2019; 29:48-54. [PMID: 30687970 PMCID: PMC6850321 DOI: 10.1111/tme.12573] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/14/2017] [Revised: 10/02/2018] [Accepted: 11/30/2018] [Indexed: 01/19/2023]
Abstract
Objectives To assess the efficacy and safety of intravenous immunoglobulin (IVIG) 10% (Panzyga®), a novel human normal IVIG 10%, in patients with chronic immune thrombocytopenia (ITP). Background First‐line treatment options in ITP include IVIGs. Methods In this prospective, open‐label, non‐controlled, multicentre, phase III study, patients received a daily dose of IVIG 10% (1 g kg−1 body weight) for two consecutive days. The primary end point was clinical response rate; secondary end points included alternate response definitions, time to response, response duration, platelet counts, regression of bleeding and safety. Results Forty patients were enrolled (57·5% male, mean age 36·7 years); the full analysis set comprised 36 patients. A clinical response was seen for 29 of 36 patients (80·6%). Median time to response and response duration was 2 days and 14 days, respectively. IVIG 10% was well tolerated at a maximum infusion rate of 8 mg (kg min)−1 in all but one patient; adverse events were mainly mild to moderate in severity, and the most frequent was headache (42·5%). Conclusion IVIG 10% is well tolerated even at a high infusion speed and induces a rapid platelet count increase, thus decreasing the bleeding rate and the severity of bleeding events. Trial registry: http://ClinicalTrials.gov record: NCT01349790.
Collapse
Affiliation(s)
- O Arbach
- Immunhaematology, Institut für Transfusionsmedizin, Universitätsmedizin Berlin, Berlin, Germany.,SPARK/Validation Fund, Berlin Health Innovations, Berlin, Germany
| | - A B Taumberger
- Clinical Project Management, Octapharma Pharmazeutika Produktionsges.m.b.H., Vienna, Austria
| | - S Wietek
- Clinical Project Management, Octapharma Pharmazeutika Produktionsges.m.b.H., Vienna, Austria
| | - L Cervinek
- Department of Internal Medicine, Hematology and Oncology, University Hospital Brno, Brno, Czech Republic
| | - A Salama
- Immunhaematology, Institut für Transfusionsmedizin, Universitätsmedizin Berlin, Berlin, Germany.,Klinik für Gynäkologie, Campus Virchow-Klinikum, Charite Universitätsmedizin Berlin, Berlin, Germany
| |
Collapse
|
27
|
Mohidin B, Bass P, Salama A, Hamour S. Malignant renal obstruction without dilatation. Acute Med 2019; 18:121-123. [PMID: 31127802] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/09/2023]
Abstract
A 61 year old male presented with a one-week history of abdominal pain and loose stools. He had recently received treatment for cellulitis with flucloxacillin. He was anuric on presentation requiring haemodialysis. His ultrasound scan showed patent vessels with no signs of obstruction. A kidney biopsy revealed tubulointerstitial nephritis, attributed to recent treatment with flucloxacillin. A week later he developed lower limb thromboembolic disease triggering further investigations. A FDG PET-CT scan revealed a large FDG-avid retroperitoneal mass causing non-dilated obstruction of both kidneys. Bilateral retrograde stents were inserted which resulted in a 1.6L diuresis and cessation of haemodialysis. Non-dilated obstruction should be considered in anuric AKI, particularly in the context of malignancy, and may require a therapeutic trial of decompression.
Collapse
Affiliation(s)
- B Mohidin
- MRCP, Core Medical Trainee, University College London Centre for Nephrology, Royal Free Hospital, London, United Kingdom
| | - P Bass
- FRCPath, Consultant Histopathologist, University College London Centre for Nephrology, Royal Free Hospital, London, United Kingdom
| | - A Salama
- FRCP, Consultant Nephrologist, University College London Centre for Nephrology, Royal Free Hospital, London, United Kingdom
| | - S Hamour
- MRCP, Consultant Nephrologist, University College London Centre for Nephrology, Royal Free Hospital, London, United Kingdom
| |
Collapse
|
28
|
Al Atassi H, Shapiro MC, Rao SR, Dean J, Salama A. Oral and Maxillofacial Surgery Resident Perception of Personal Achievement and Anxiety: A Cross-Sectional Analysis. J Oral Maxillofac Surg 2018; 76:2532-2539. [DOI: 10.1016/j.joms.2018.06.018] [Citation(s) in RCA: 21] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/13/2018] [Revised: 06/13/2018] [Accepted: 06/13/2018] [Indexed: 12/20/2022]
|
29
|
Yost S, Stashenko P, Choi Y, Kukuruzinska M, Genco CA, Salama A, Weinberg EO, Kramer CD, Frias-Lopez J. Increased virulence of the oral microbiome in oral squamous cell carcinoma revealed by metatranscriptome analyses. Int J Oral Sci 2018; 10:32. [PMID: 30420594 PMCID: PMC6232154 DOI: 10.1038/s41368-018-0037-7] [Citation(s) in RCA: 75] [Impact Index Per Article: 12.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/16/2018] [Revised: 08/22/2018] [Accepted: 08/28/2018] [Indexed: 02/06/2023] Open
Abstract
Oral squamous cell carcinoma (OSCC) is the most prevalent and most commonly studied oral cancer. However, there is a void regarding the role that the oral microbiome may play in OSCC. Although the relationship between microbial community composition and OSCC has been thoroughly investigated, microbial profiles of the human microbiome in cancer are understudied. Here we performed a small pilot study of community-wide metatranscriptome analysis to profile mRNA expression in the entire oral microbiome in OSCC to reveal molecular functions associated with this disease. Fusobacteria showed a statistically significantly higher number of transcripts at tumour sites and tumour-adjacent sites of cancer patients compared to the healthy controls analysed. Regardless of the community composition, specific metabolic signatures were consistently found in disease. Activities such as iron ion transport, tryptophanase activity, peptidase activities and superoxide dismutase were over-represented in tumour and tumour-adjacent samples when compared to the healthy controls. The expression of putative virulence factors in the oral communities associated with OSCC showed that activities related to capsule biosynthesis, flagellum synthesis and assembly, chemotaxis, iron transport, haemolysins and adhesins were upregulated at tumour sites. Moreover, activities associated with protection against reactive nitrogen intermediates, chemotaxis, flagellar and capsule biosynthesis were also upregulated in non-tumour sites of cancer patients. Although they are preliminary, our results further suggest that Fusobacteria may be the leading phylogenetic group responsible for the increase in expression of virulence factors in the oral microbiome of OSCC patients.
Collapse
Affiliation(s)
- Susan Yost
- Forsyth Institute, 245 First Street, Cambridge, MA, 02142, USA
| | - Philip Stashenko
- Boston University Henry M. Goldman School of Dental Medicine, 100 East Newton Street, Boston, MA, 02118, USA
| | - Yoonhee Choi
- Forsyth Institute, 245 First Street, Cambridge, MA, 02142, USA
| | - Maria Kukuruzinska
- Boston University Henry M. Goldman School of Dental Medicine, 100 East Newton Street, Boston, MA, 02118, USA
| | - Caroline A Genco
- Department of Integrative Physiology and Pathobiology, Tufts University School of Medicine, 136 Harrison Avenue, Boston, MA, 02111, USA
| | - Andrew Salama
- Boston University Henry M. Goldman School of Dental Medicine, 100 East Newton Street, Boston, MA, 02118, USA
| | - Ellen O Weinberg
- Department of Integrative Physiology and Pathobiology, Tufts University School of Medicine, 136 Harrison Avenue, Boston, MA, 02111, USA
| | - Carolyn D Kramer
- Department of Integrative Physiology and Pathobiology, Tufts University School of Medicine, 136 Harrison Avenue, Boston, MA, 02111, USA
| | - Jorge Frias-Lopez
- Department of Oral Biology, College of Dentistry, University of Florida, 1395 Center Drive, Gainesville, FL, 32610-0424, USA.
| |
Collapse
|
30
|
Attallah AM, Omran D, Marie MS, Abdelrazek M, Salama A, El Essawey R, Mobarak L, Maklad S, Omar A. IL-28B rs12979860 polymorphism affect the course of chronic hepatitis and the development of HCC in Egyptian patients with hepatitis C type 4. Br J Biomed Sci 2018; 75:157-162. [PMID: 29914308 DOI: 10.1080/09674845.2018.1489599] [Citation(s) in RCA: 12] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/07/2018] [Accepted: 05/07/2018] [Indexed: 12/16/2022]
Abstract
BACKGROUND A single nucleotide polymorphism (SNP) in the interleukin 28B (IL28B) gene may alter the trajectory of hepatitis C virus (HCV) chronic infection. Several studies have sought to determine a link between IL28B rs12979860 SNP and the development of HCV-related hepatocellular carcinoma (HCC), but with variable results, and consensus is awaited. We hypothesised that IL28B rs12979860 SNP is linked to HCC in patients with HCV type 4. METHODS IL28B genotyping of 300 patients with HCV-related fibrosis (n = 100), cirrhosis (n = 100) and HCC (n = 100) was carried out and the results were analysed to determine the association between the IL28B genotype and clinical outcome. RESULTS In IL28B TT genotype carriers, the proportions of moderate/severe fibrosis, advanced cirrhosis (Child B-C) and HCC (50%, 84% and 60.2%, respectively) were higher (p < 0.05) than in CC/CT (4.3%, 46% and 23%, respectively). IL-28B SNP was linked significantly (p < 0.05) with cirrhosis progression and HCC advanced stages. Moreover, HCC advanced Child, Okuda and CLIP stages were associated with T allele carriage (73.9%, 82.6% and 78.3% vs. 44.2%, 50.6% and 46.8% in CC/CT). The percentage of large tumour size (> 3cm) increased (p = 0.028) in TT genotype carriers (81.8% vs.52.6% in CC/CT). CONCLUSION IL-28B rs12979860 TT genotype is more prevalent in patients with advanced fibrosis, cirrhosis and HCC stages. Thus, it seems to be associated with poor outcomes in chronic HCV patients and to augment the risk of developing HCC.
Collapse
Affiliation(s)
- A M Attallah
- a Research & Development Department , Biotechnology Research Center , New Damietta , Egypt
| | - D Omran
- b Department of Endemic Medicine and Hepatology, Faculty of Medicine , Cairo University , Cairo , Egypt
| | - M S Marie
- b Department of Endemic Medicine and Hepatology, Faculty of Medicine , Cairo University , Cairo , Egypt
| | - Mohamed Abdelrazek
- a Research & Development Department , Biotechnology Research Center , New Damietta , Egypt
| | - A Salama
- b Department of Endemic Medicine and Hepatology, Faculty of Medicine , Cairo University , Cairo , Egypt
| | - R El Essawey
- c Department of Clinical and Chemical pathology, Faculty of Medicine , Cairo University , Cairo , Egypt
| | - L Mobarak
- d National Hepatology and Tropical Medicine Research Institute , Cairo , Egypt
| | - S Maklad
- d National Hepatology and Tropical Medicine Research Institute , Cairo , Egypt
| | - A Omar
- b Department of Endemic Medicine and Hepatology, Faculty of Medicine , Cairo University , Cairo , Egypt
| |
Collapse
|
31
|
Dean J, Shapiro MC, Al Atassi H, Salama A. In Reply. J Oral Maxillofac Surg 2018; 76:2248-2249. [PMID: 30118669 DOI: 10.1016/j.joms.2018.07.019] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/13/2018] [Accepted: 07/14/2018] [Indexed: 11/19/2022]
|
32
|
Salama A, Richard G, Medles K, Zeghloul T, Dascalescu L. Distinct recovery of copper and aluminum from waste electric wires using a roll-type electrostatic separator. Waste Manag 2018; 76:207-216. [PMID: 29605307 DOI: 10.1016/j.wasman.2018.03.036] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/29/2017] [Revised: 02/28/2018] [Accepted: 03/23/2018] [Indexed: 06/08/2023]
Abstract
Electrostatic separators are commonly employed for the sorting of insulating and conducting fractions of granular mixtures. However, separation of the various metals that compose the conductive fraction still represents a major challenge for the recycling industry. The aim of this paper is to identify the conditions in which a roll-type electrostatic separator could be used for distinctly recover the copper and aluminum from waste electric wires. A numerical model of particle trajectories was employed to predefine these conditions and guide the experimental study. The electrostatic separation experiments were carried out using a reverse-S-type-plate high-voltage electrode. The visualization of particle trajectories using a high-speed camera paved the way to an original design. Thus, a metallic trap was attached to the high-voltage electrode, to facilitate the collection of the aluminum flake-like particles from a mixture that also contains copper strands. With a plastic trap replacing the metallic one, to avoid electric field modification, 68.6% of the copper was recovered with a purity attaining 99%.
Collapse
Affiliation(s)
- A Salama
- PPRIME Institute, CNRS, University of Poitiers, ENSMA, IUT, Angoulême, France; Shoubra Faculty of Engineering, Benha University, Cairo, Egypt
| | - G Richard
- PPRIME Institute, CNRS, University of Poitiers, ENSMA, IUT, Angoulême, France; CITF, Saint Cybardeaux, France
| | - K Medles
- PPRIME Institute, CNRS, University of Poitiers, ENSMA, IUT, Angoulême, France; University of Sidi-Bel-Abbes, Algeria
| | - T Zeghloul
- PPRIME Institute, CNRS, University of Poitiers, ENSMA, IUT, Angoulême, France
| | - L Dascalescu
- PPRIME Institute, CNRS, University of Poitiers, ENSMA, IUT, Angoulême, France.
| |
Collapse
|
33
|
Kirke DN, Qureshi MM, Kamran SC, Ezzat W, Jalisi S, Salama A, Everett PC, Truong MT. Role of adjuvant chemoradiotherapy in T4N0 stage IV head and neck cancer: A National Cancer Database analysis. Head Neck 2018; 40:1174-1184. [PMID: 29417687 DOI: 10.1002/hed.25087] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/03/2017] [Revised: 10/04/2017] [Accepted: 12/20/2017] [Indexed: 12/18/2022] Open
Abstract
BACKGROUND The purpose of this study was to evaluate the role of postoperative adjuvant radiotherapy (surgery + adjuvant RT) versus adjuvant chemoradiotherapy (surgery + adjuvant CRT) in patients with T4N0M0, stage IV head and neck squamous cell carcinoma (HNSCC). METHODS Between 1998 and 2011, 3518 and 885 patients were treated with surgery + adjuvant RT and surgery + adjuvant CRT, respectively. Three-year overall survival (OS) rates were determined and crude and adjusted hazard ratios (HRs) with 95% confidence intervals (CIs) were computed. RESULTS Median follow-up was 41.8 months with 2193 reported deaths. The 3-year OS was 67.5% for surgery + adjuvant RT and 70.5% for surgery + adjuvant CRT (P = .013). For negative margins, the corresponding 3-year OS was 70.1% and 74.9% (P = .005). For positive margins, the corresponding 3-year OS was 56.0% and 60.6% (P = .079). On multivariate analysis, the beneficial effect for adjuvant CRT over adjuvant RT was not significant (HR 0.90; CI 0.79-1.03; P = .124). CONCLUSION In this cohort of patients with T4N0 HNSCC treated with surgery, there was no observed survival benefit of adjuvant CRT over adjuvant RT on multivariate analysis.
Collapse
Affiliation(s)
- Diana N Kirke
- Department of Otolaryngology - Head and Neck Surgery, Boston Medical Center, Boston, Massachusetts
| | - Muhammad M Qureshi
- Department of Radiation Oncology, Boston Medical Center, Boston, Massachusetts
| | | | - Waleed Ezzat
- Department of Otolaryngology - Head and Neck Surgery, Boston Medical Center, Boston, Massachusetts
| | - Scharukh Jalisi
- Department of Otolaryngology - Head and Neck Surgery, Boston Medical Center, Boston, Massachusetts
| | - Andrew Salama
- Department of Oral and Maxillofacial Surgery, Boston Medical Center, Boston, Massachusetts
| | - Peter C Everett
- Division of Hematology Oncology, Department of Medicine, Boston Medical Center, Boston University School of Medicine, Boston, Massachusetts
| | - Minh Tam Truong
- Department of Radiation Oncology, Boston Medical Center, Boston, Massachusetts
| |
Collapse
|
34
|
Salama A, Fathi M, Badr MR, Moawad AR. 127 L-Carnitine Supplementation During In Vitro Maturation Improves Developmental Competence of Canine Oocytes. Reprod Fertil Dev 2018. [DOI: 10.1071/rdv30n1ab127] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022] Open
Abstract
In vitro embryo production (IVP) in the domestic bitch is important for conservation of endangered canids. Compared with various domestic animals, the development of assisted reproductive technologies (ART) in the dog has lagged behind, mainly due to the low percentage of oocytes that can reach metaphase II (MII) stage after in vitro maturation (IVM). Beneficial effects of l-carnitine (LC) on embryonic development in culture have been reported in many mammalian species; however, no studies have been conducted in dogs. The aim of the present study was to investigate the effect of LC supplementation during IVM of canine oocytes on nuclear maturation, fertilization status, and pre-implantation development following IVM/IVF. Cumulus-oocyte complexes (COC) were collected by slicing ovaries obtained from dogs (n = 20, 1 to 6 years of age) after ovariohysterectomy. The COC were subjected to IVM for 72 h in a medium (TCM-199) supplemented with LC at different concentrations (0.1, 0.3, 0.6, 1.0, or 2.0 mg mL−1) or without LC supplements (0 mg mL−1; control). Matured oocytes were fertilized in vitro with frozen–thawed spermatozoa, and presumptive zygotes were cultured in SOF medium for 7 days. Frequencies of nuclear maturation (72 h post-IVM), fertilization rates (18 h post-insemination), and embryo development (Days 2 to 5 post-insemination) were evaluated. Data were analysed by one-way ANOVA followed by Tukey’s multiple comparisons test. Supplementation of IVM medium with 0.3 or 0.6 mg mL−1 LC significantly improved (P ≤ 0.05) maturation (35.4% and 41.4%) and fertilization (21.3% and 25.8%) rates compared with the controls and with other LC-supplemented groups; values ranged from 20.1% to 25.0% for maturation and from 12.1% to 14.6% for fertilization. Cleavage (2- to 16-cell stages) was significantly higher (P ≤ 0.05) in the 0.6 mg mL−1 LC supplemented group than the 0.3 mg mL−1 supplemented group (16.3% v. 13.3%). These values were significantly higher (P ≤ 0.05) than those in other groups. Interestingly, 4.5% of IVM/IVF oocytes were developed to morula in 0.6 mg mL−1 LC supplemented group which was significantly higher (P ≤ 0.05) than those developed in the 0.3 mg mL−1 supplemented group (1.0%). No embryos developed beyond the 2- to 16-cell stage in the rest of the groups. In conclusion, l-carnitine supplementation during IVM is particularly efficient in improving nuclear maturation and pre-implantation embryo development of canine oocytes after IVF. These outcomes are important for the improvement of IVM conditions that can advance the efficiency of ART in dogs.
Collapse
|
35
|
Ziemer S, Radtke H, Schmutzler M, Kiesewetter H, Salama A, von Tempelhoff GF, Koscielny J. Präoperative Identifikation von Patienten mit (primären) Hämostasestörungen. Hamostaseologie 2017. [DOI: 10.1055/s-0037-1616908] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022] Open
Abstract
ZusammenfassungWir präsentieren eine große prospektive Untersuchung, in der vor großen elektiven operativen Eingriffen nach Hämostasestörungen ein Screening erfolgte. 5649 erwachsene, nicht selektierte Patienten (2631 Frauen, 3018 Männer) wurden über ein Jahr im Universitätsklinikum Charité untersucht. Ein standardisierter Fragebogen mit 12 Fragen wurde benutzt. Des Weiteren wurden die plasmatischen Routinegerinnungstests (aPTT, PT) mit der Thrombozytenzählung und die In-vitro-Verschlusszeiten (PFA 100: Kollagen- Epinephrin, Kollagen-ADP) gemessen. Wenn die Blutungsanamnese positiv (eine Frage positiv beantwortet) war, wurden folgende Screening-Tests zusätzlich durchgeführt: In-vivo-Blutungszeit (Surgicutt), von-Willebrand- Faktor (VWF : Ag, VWF : Rcof) und weiterführende hämostaseologische Differenzialdiagnostik. Ergebnisse: Die Blutungsanamnese war negativ bei 5021 Patienten (88,8%) und positiv bzw. enthielt einen Hinweis auf Medikamente, die eine Hämostasestörung induzieren können, bei 628 Patienten (11,2%). Hämostasestörungen wurden bei 256 (40,8%) in dieser letzten Patientengruppe gefunden. Die meisten der Patienten mit Hämostasestörungen wurden mit dem PFA-100: C/E (n=250; 97,7%) identifiziert. Die Sensitivität des PFA-100: Kollagen-Epinephrin war am höchsten (90,8%) im Vergleich zu anderen Screeningtests (BT, aPTT, PT, VWF : Ag). Der positive Vorhersagewert (zu Erkennung von Hämostasestörungen) des PFA-100: Kollagen- Epinephrin mit der standardisierten Blutungsanamnese war hoch (82%), aber der negative war mit 93% höher. Schlussfolgerungen: Primäre Hämostasestörungen treten häufiger als plasmatische Hämostasestörungen auf. Ein standardisierter Fragebogen zur Blutungsanamnese und, sofern indiziert, der PFA-100: Kollagen-Epinephrin und/ oder weitere spezifische Tests können zu einer signifikanten Reduktion der Kosten bei einer hohen Identifikationssrate von vorwiegend primären Hämostasestörungen führen. Nationale Empfehlungen sind bereits formuliert.
Collapse
|
36
|
Elsokkary M, Mamdouh A, Nossair W, Abd El Fattah O, Hemeda H, Sallam S, Taema M, Hussain M, Shafik A, Nawara M, Samy M, Abd El Aleem M, Abdelhadi R, Sakna N, Salama A, Salama D, El-Tohamy O, Elsaid N. Significance of assay of nucleated RBCs in umbilical cord blood in neonates with meconium-stained amniotic fluid. J Matern Fetal Neonatal Med 2017; 32:483-487. [PMID: 29219012 DOI: 10.1080/14767058.2017.1384457] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
Abstract
BACKGROUND Approximately 8-15% of all infants are born with evidence of meconium-stained amniotic fluid (MSAF). MSAF is a potentially serious sign of fetal compromise and may indicate fetal hypoxia Objectives and aim of the work: The present study was designed to evaluate the relationship between meconium stained amniotic fluid and fetal nucleated red blood cell counts. As well, we aim to evaluate the relationship between the presence of meconium in amniotic fluid and Apgar scores in neonates. SUBJECTS AND METHODS A prospectively case-controlled study was performed on 40 women with clear amniotic fluid as control and 40 women with meconium-stained amniotic fluid as the study group. At delivery, 2 ml of umbilical cord blood was collected and analyzed for nucleated red blood cell (NRBC). RESULTS The mean NRBC counts in meconium-stained amniotic fluid was significantly higher than the control group (18.35 ± 7.7 and 9.6 ± 4.96), respectively (p < .001). There were statistically significant differences concerning 1- and 5-min Apgar scores with lower values in the MSAF group (p < .001 and .001, respectively). CONCLUSION Our results support previous studies which indicate the presence of meconium can be associated with chronic fetal hypoxia as demonstrated by elevated fetal NRBC levels.
Collapse
Affiliation(s)
- M Elsokkary
- a Department of Obstetrics and Gynecology , Ain Shams University , Cairo , Egypt
| | - A Mamdouh
- a Department of Obstetrics and Gynecology , Ain Shams University , Cairo , Egypt
| | - W Nossair
- b Department of Obstetrics and Gynecology , Faculty of Medicine, Zagazig University , Cairo , Egypt
| | - O Abd El Fattah
- c Department of Reproductive Health Research , National Research Centre , Cairo , Egypt
| | - H Hemeda
- a Department of Obstetrics and Gynecology , Ain Shams University , Cairo , Egypt
| | - S Sallam
- d Department of Obstetrics and Gynecology , Al-Arish Hospital , Cairo , Egypt
| | - M Taema
- a Department of Obstetrics and Gynecology , Ain Shams University , Cairo , Egypt
| | - M Hussain
- a Department of Obstetrics and Gynecology , Ain Shams University , Cairo , Egypt
| | - A Shafik
- a Department of Obstetrics and Gynecology , Ain Shams University , Cairo , Egypt
| | - M Nawara
- a Department of Obstetrics and Gynecology , Ain Shams University , Cairo , Egypt
| | - M Samy
- a Department of Obstetrics and Gynecology , Ain Shams University , Cairo , Egypt
| | - M Abd El Aleem
- a Department of Obstetrics and Gynecology , Ain Shams University , Cairo , Egypt
| | - R Abdelhadi
- a Department of Obstetrics and Gynecology , Ain Shams University , Cairo , Egypt
| | - N Sakna
- a Department of Obstetrics and Gynecology , Ain Shams University , Cairo , Egypt
| | - A Salama
- a Department of Obstetrics and Gynecology , Ain Shams University , Cairo , Egypt
| | - D Salama
- e National Center for Radiation Research and Technology, Atomic Energy Authority , Cairo , Egypt
| | - O El-Tohamy
- a Department of Obstetrics and Gynecology , Ain Shams University , Cairo , Egypt
| | - N Elsaid
- a Department of Obstetrics and Gynecology , Ain Shams University , Cairo , Egypt
| |
Collapse
|
37
|
Patel S, Hodi F, Gabrilovich D, Chin M, Gibney G, Goldsberry A, Gonzalez R, Hurt J, Markowitz J, Whitman E, Meyer C, Salama A. A phase 1b/2 study of omaveloxolone in combination with checkpoint inhibitors in patients with unresectable or metastatic melanoma. Ann Oncol 2017. [DOI: 10.1093/annonc/mdx760] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
38
|
Kamran SC, Qureshi MM, Jalisi S, Salama A, Grillone G, Truong MT. Primary surgery versus primary radiation‐based treatment for locally advanced oropharyngeal cancer. Laryngoscope 2017; 128:1353-1364. [DOI: 10.1002/lary.26903] [Citation(s) in RCA: 20] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/09/2017] [Revised: 07/26/2017] [Accepted: 08/15/2017] [Indexed: 01/21/2023]
Affiliation(s)
- Sophia C. Kamran
- Department of Radiation OncologyBoston Medical Center, Boston University School of MedicineBoston Massachusetts U.S.A
- Harvard Radiation Oncology ProgramBoston Massachusetts U.S.A
| | - Muhammad M. Qureshi
- Department of Radiation OncologyBoston Medical Center, Boston University School of MedicineBoston Massachusetts U.S.A
| | - Scharukh Jalisi
- Department of Otolaryngology, Head and Neck SurgeryBoston Medical Center, Boston University School of MedicineBoston Massachusetts U.S.A
| | - Andrew Salama
- Department of Oral and Maxillofacial SurgeryBoston Medical Center, Boston University Henry M. Goldman School of Dental MedicineBoston Massachusetts U.S.A
| | - Gregory Grillone
- Department of Otolaryngology, Head and Neck SurgeryBoston Medical Center, Boston University School of MedicineBoston Massachusetts U.S.A
| | - Minh Tam Truong
- Department of Radiation OncologyBoston Medical Center, Boston University School of MedicineBoston Massachusetts U.S.A
| |
Collapse
|
39
|
Pynnonen MA, Gillespie MB, Roman B, Rosenfeld RM, Tunkel DE, Bontempo L, Brook I, Chick DA, Colandrea M, Finestone SA, Fowler JC, Griffith CC, Henson Z, Levine C, Mehta V, Salama A, Scharpf J, Shatzkes DR, Stern WB, Youngerman JS, Corrigan MD. Clinical Practice Guideline: Evaluation of the Neck Mass in Adults Executive Summary. Otolaryngol Head Neck Surg 2017; 157:355-371. [PMID: 28891424 DOI: 10.1177/0194599817723609] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
The American Academy of Otolaryngology-Head and Neck Surgery Foundation has published a supplement to this issue of Otolaryngology-Head and Neck Surgery featuring the "Clinical Practice Guideline: Evaluation of the Neck Mass in Adults." To assist in implementing the guideline recommendations, this article summarizes the rationale, purpose, and key action statements. The 12 recommendations developed emphasize reducing delays in diagnosis of head and neck squamous cell carcinoma; promoting appropriate testing, including imaging, pathologic evaluation, and empiric medical therapies; reducing inappropriate testing; and promoting appropriate physical examination when cancer is suspected.
Collapse
Affiliation(s)
| | - M Boyd Gillespie
- 2 University of Tennessee Health Science Center, Memphis, Tennessee, USA
| | - Benjamin Roman
- 3 Memorial Sloan Kettering Cancer Center, New York, New York, USA
| | - Richard M Rosenfeld
- 4 SUNY Downstate Medical Center, Long Island College Hospital, New York, New York, USA
| | | | - Laura Bontempo
- 6 University of Maryland School of Medicine, Baltimore, Maryland, USA
| | | | | | - Maria Colandrea
- 8 Veterans Affairs Medical Center, Durham, North Carolina, USA.,9 Duke University School of Nursing, Durham, North Carolina, USA
| | - Sandra A Finestone
- 10 Consumers United for Evidence-Based Healthcare, Baltimore, Maryland, USA
| | | | | | - Zeb Henson
- 13 University of Mississippi Medical Center, Jackson, Mississippi, USA
| | | | - Vikas Mehta
- 15 Lousiana State University, Shreveport, Louisiana, USA
| | | | | | - Deborah R Shatzkes
- 18 Hofstra Northwell School of Medicine, Lenox Hill Hospital, New York, New York, USA
| | - Wendy B Stern
- 19 Southcoast Hospital, North Dartmouth, Massachusetts, USA
| | | | - Maureen D Corrigan
- 21 American Academy of Otolaryngology-Head and Neck Surgery Foundation, Alexandria, Virginia, USA
| |
Collapse
|
40
|
Pynnonen MA, Gillespie MB, Roman B, Rosenfeld RM, Tunkel DE, Bontempo L, Brook I, Chick DA, Colandrea M, Finestone SA, Fowler JC, Griffith CC, Henson Z, Levine C, Mehta V, Salama A, Scharpf J, Shatzkes DR, Stern WB, Youngerman JS, Corrigan MD. Clinical Practice Guideline: Evaluation of the Neck Mass in Adults. Otolaryngol Head Neck Surg 2017; 157:S1-S30. [PMID: 28891406 DOI: 10.1177/0194599817722550] [Citation(s) in RCA: 64] [Impact Index Per Article: 9.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/22/2022]
Abstract
Objective Neck masses are common in adults, but often the underlying etiology is not easily identifiable. While infections cause most of the neck masses in children, most persistent neck masses in adults are neoplasms. Malignant neoplasms far exceed any other etiology of adult neck mass. Importantly, an asymptomatic neck mass may be the initial or only clinically apparent manifestation of head and neck cancer, such as squamous cell carcinoma (HNSCC), lymphoma, thyroid, or salivary gland cancer. Evidence suggests that a neck mass in the adult patient should be considered malignant until proven otherwise. Timely diagnosis of a neck mass due to metastatic HNSCC is paramount because delayed diagnosis directly affects tumor stage and worsens prognosis. Unfortunately, despite substantial advances in testing modalities over the last few decades, diagnostic delays are common. Currently, there is only 1 evidence-based clinical practice guideline to assist clinicians in evaluating an adult with a neck mass. Additionally, much of the available information is fragmented, disorganized, or focused on specific etiologies. In addition, although there is literature related to the diagnostic accuracy of individual tests, there is little guidance about rational sequencing of tests in the course of clinical care. This guideline strives to bring a coherent, evidence-based, multidisciplinary perspective to the evaluation of the neck mass with the intention to facilitate prompt diagnosis and enhance patient outcomes. Purpose The primary purpose of this guideline is to promote the efficient, effective, and accurate diagnostic workup of neck masses to ensure that adults with potentially malignant disease receive prompt diagnosis and intervention to optimize outcomes. Specific goals include reducing delays in diagnosis of HNSCC; promoting appropriate testing, including imaging, pathologic evaluation, and empiric medical therapies; reducing inappropriate testing; and promoting appropriate physical examination when cancer is suspected. The target patient for this guideline is anyone ≥18 years old with a neck mass. The target clinician for this guideline is anyone who may be the first clinician whom a patient with a neck mass encounters. This includes clinicians in primary care, dentistry, and emergency medicine, as well as pathologists and radiologists who have a role in diagnosing neck masses. This guideline does not apply to children. This guideline addresses the initial broad differential diagnosis of a neck mass in an adult. However, the intention is only to assist the clinician with a basic understanding of the broad array of possible entities. The intention is not to direct management of a neck mass known to originate from thyroid, salivary gland, mandibular, or dental pathology as management recommendations for these etiologies already exist. This guideline also does not address the subsequent management of specific pathologic entities, as treatment recommendations for benign and malignant neck masses can be found elsewhere. Instead, this guideline is restricted to addressing the appropriate work-up of an adult patient with a neck mass that may be malignant in order to expedite diagnosis and referral to a head and neck cancer specialist. The Guideline Development Group sought to craft a set of actionable statements relevant to diagnostic decisions made by a clinician in the workup of an adult patient with a neck mass. Furthermore, where possible, the Guideline Development Group incorporated evidence to promote high-quality and cost-effective care. Action Statements The development group made a strong recommendation that clinicians should order a neck computed tomography (or magnetic resonance imaging) with contrast for patients with a neck mass deemed at increased risk for malignancy. The development group made the following recommendations: (1) Clinicians should identify patients with a neck mass who are at increased risk for malignancy because the patient lacks a history of infectious etiology and the mass has been present for ≥2 weeks without significant fluctuation or the mass is of uncertain duration. (2) Clinicians should identify patients with a neck mass who are at increased risk for malignancy based on ≥1 of these physical examination characteristics: fixation to adjacent tissues, firm consistency, size >1.5 cm, or ulceration of overlying skin. (3) Clinicians should conduct an initial history and physical examination for patients with a neck mass to identify those with other suspicious findings that represent an increased risk for malignancy. (4) For patients with a neck mass who are not at increased risk for malignancy, clinicians or their designees should advise patients of criteria that would trigger the need for additional evaluation. Clinicians or their designees should also document a plan for follow-up to assess resolution or final diagnosis. (5) For patients with a neck mass who are deemed at increased risk for malignancy, clinicians or their designees should explain to the patient the significance of being at increased risk and explain any recommended diagnostic tests. (6) Clinicians should perform, or refer the patient to a clinician who can perform, a targeted physical examination (including visualizing the mucosa of the larynx, base of tongue, and pharynx) for patients with a neck mass deemed at increased risk for malignancy. (7) Clinicians should perform fine-needle aspiration (FNA) instead of open biopsy, or refer the patient to someone who can perform FNA, for patients with a neck mass deemed at increased risk for malignancy when the diagnosis of the neck mass remains uncertain. (8) For patients with a neck mass deemed at increased risk for malignancy, clinicians should continue evaluation of patients with a cystic neck mass, as determined by FNA or imaging studies, until a diagnosis is obtained and should not assume that the mass is benign. (9) Clinicians should obtain additional ancillary tests based on the patient's history and physical examination when a patient with a neck mass is deemed at increased risk for malignancy who does not have a diagnosis after FNA and imaging. (10) Clinicians should recommend evaluation of the upper aerodigestive tract under anesthesia, before open biopsy, for patients with a neck mass deemed at increased risk for malignancy and without a diagnosis or primary site identified with FNA, imaging, and/or ancillary tests. The development group recommended against clinicians routinely prescribing antibiotic therapy for patients with a neck mass unless there are signs and symptoms of bacterial infection.
Collapse
Affiliation(s)
| | - M Boyd Gillespie
- 2 Universityy of Tennessee Health Science Center, Memphis, Tennessee, USA
| | - Benjamin Roman
- 3 Memorial Sloan Kettering Cancer Center, New York, New York, USA
| | - Richard M Rosenfeld
- 4 SUNY Downstate Medical Center, Long Island College Hospital, New York, New York, USA
| | | | - Laura Bontempo
- 6 University of Maryland School of Medicine, Baltimore, Maryland, USA
| | | | | | - Maria Colandrea
- 8 Veterans Affairs Medical Center, Durham, North Carolina, USA.,9 Duke University School of Nursing, Durham, North Carolina, USA
| | - Sandra A Finestone
- 10 Consumers United for Evidence-Based Healthcare, Baltimore, Maryland, USA
| | | | | | - Zeb Henson
- 13 University of Mississippi Medical Center, Jackson, Mississippi, USA
| | | | - Vikas Mehta
- 15 Lousiana State University, Shreveport, Louisiana, USA
| | | | | | - Deborah R Shatzkes
- 18 Hofstra Northwell School of Medicine, Lenox Hill Hospital, New York, New York, USA
| | - Wendy B Stern
- 19 Southcoast Hospital, North Dartmouth, Massachusetts, USA
| | | | - Maureen D Corrigan
- 21 American Academy of Otolaryngology-Head and Neck Surgery Foundation, Alexandria, Virginia, USA
| |
Collapse
|
41
|
Abdelhamid T, Saber M, Abdel-Samie Gaber A, Selim M, Youssef O, Salama A, Aly Eldin N. Efficacy and safety profile of the adriamycin/cyclophosphamide (AC) followed by docetaxel/cisplatin (DC) in locally advanced breast cancer. Ann Oncol 2017. [DOI: 10.1093/annonc/mdx364.013] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
42
|
|
43
|
Salama A, Göttsche B, Vaidya V, Santoso S, Mueller-Eckhardt C. Complement-Independent Lysis of Human Red Blood Cells by
Cold Hemagglutinins. Vox Sang 2017. [DOI: 10.1159/000461824] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
|
44
|
|
45
|
Alsaqer SF, Tashkandi MM, Kartha VK, Yang YT, Alkheriji Y, Salama A, Varelas X, Kukuruzinska M, Monti S, Bais MV. Inhibition of LSD1 epigenetically attenuates oral cancer growth and metastasis. Oncotarget 2017; 8:73372-73386. [PMID: 29088714 PMCID: PMC5650269 DOI: 10.18632/oncotarget.19637] [Citation(s) in RCA: 38] [Impact Index Per Article: 5.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/28/2016] [Accepted: 07/14/2017] [Indexed: 01/26/2023] Open
Abstract
Lysine-specific demethylase 1 (LSD1) is a nuclear histone demethylase and a member of the amine oxidase (AO) family. LSD1 is a flavin-containing AO that specifically catalyzes the demethylation of mono- and di-methylated histone H3 lysine 4 through an FAD-dependent oxidative reaction. LSD1 is inappropriately upregulated in lung, liver, brain and esophageal cancers, where it promotes cancer initiation, progression, and metastasis. However, unlike other lysine-specific demethylases, the role and specific targets of LSD1 in oral squamous cell carcinoma (OSCC) pathogenesis remain unknown. We show that LSD1 protein expression was increased in malignant OSCC tissues in a clinical tissue microarray, and its expression correlated with progressive tumor stages. In an orthotopic oral cancer mouse model, LSD1 overexpression in aggressive HSC-3 cells promoted metastasis whereas knockdown of LSD1 inhibited tumor spread, suggesting that LSD1 is a key regulator of OSCC metastasis. Pharmacological inhibition of LSD1 using a specific small molecule inhibitor, GSK-LSD1, down-regulated EGF signaling pathway. Further, GSK-LSD1 attenuates CTGF/CCN2, MMP13, LOXL4 and vimentin expression but increased E-cadherin expression in pre-existing, patient-derived tonsillar OSCC xenografts. Similarly, GSK-LSD1 inhibited proliferation and CTGF expression in mesenchymal cells, including myoepithelial cells and osteosarcoma cells. In addition, gene set enrichment analysis revealed that GSK-LSD1 increased p53 expression and apoptosis while inhibiting c-myc, β-catenin and YAP-induced oncogenic transcriptional networks. These data reveal that aberrant LSD1 activation regulates key OSCC microenvironment and EMT promoting factors, including CTGF, LOXL4 and MMP13.
Collapse
Affiliation(s)
- Saqer F Alsaqer
- Department of Molecular and Cell Biology, Boston University Henry M. Goldman School of Dental Medicine, Boston, MA, USA
| | - Mustafa M Tashkandi
- Department of Molecular and Cell Biology, Boston University Henry M. Goldman School of Dental Medicine, Boston, MA, USA
| | - Vinay K Kartha
- Bioinformatics Program, Boston University, Boston, MA, USA.,Section of Computational Biomedicine, Boston University School of Medicine, Boston, MA, USA
| | - Ya-Ting Yang
- Department of Molecular and Cell Biology, Boston University Henry M. Goldman School of Dental Medicine, Boston, MA, USA
| | - Yazeed Alkheriji
- Department of Molecular and Cell Biology, Boston University Henry M. Goldman School of Dental Medicine, Boston, MA, USA
| | - Andrew Salama
- Department of Oral and Maxillofacial Surgery, Boston University Henry M. Goldman School of Dental Medicine, Boston, MA, USA
| | - Xaralabos Varelas
- Department of Biochemistry, Boston University School of Medicine, Boston, MA, USA
| | - Maria Kukuruzinska
- Department of Molecular and Cell Biology, Boston University Henry M. Goldman School of Dental Medicine, Boston, MA, USA
| | - Stefano Monti
- Bioinformatics Program, Boston University, Boston, MA, USA.,Section of Computational Biomedicine, Boston University School of Medicine, Boston, MA, USA
| | - Manish V Bais
- Department of Molecular and Cell Biology, Boston University Henry M. Goldman School of Dental Medicine, Boston, MA, USA
| |
Collapse
|
46
|
Giacalone NJ, Qureshi MM, Mak KS, Kirke D, Patel SA, Shah BA, Salama A, Jalisi S, Truong MT. (P067) Survival Outcomes With Adjuvant Chemoradiation Versus Adjuvant Radiation Alone for Elderly Patients With Resected Head and Neck Squamous Cell Carcinoma With Positive Surgical Margins or Extra-Capsular Extension. Int J Radiat Oncol Biol Phys 2017. [DOI: 10.1016/j.ijrobp.2017.02.163] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
47
|
Le Berre L, Rousse J, Gourraud PA, Imbert-Marcille BM, Salama A, Evanno G, Semana G, Nicot A, Dugast E, Guérif P, Adjaoud C, Freour T, Brouard S, Agbalika F, Marignier R, Brassat D, Laplaud DA, Drouet E, Van Pesch V, Soulillou JP. Decrease of blood anti-α1,3 Galactose Abs levels in multiple sclerosis (MS) and clinically isolated syndrome (CIS) patients. Clin Immunol 2017; 180:128-135. [PMID: 28506921 DOI: 10.1016/j.clim.2017.05.006] [Citation(s) in RCA: 21] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/21/2016] [Revised: 03/17/2017] [Accepted: 05/05/2017] [Indexed: 02/07/2023]
Abstract
The etiology of multiple sclerosis (MS) remains elusive. Among the possible causes, the increase of anti-Neu5Gc antibodies during EBV primo-infection of Infectious mononucleosis (IMN) may damage the integrity of the blood-brain barrier facilitating the transfer of EBV-infected B cells and anti-EBV T cell clones in the brain. We investigated the change in titers of anti-Neu5Gc and anti-α1,3 Galactose antibodies in 49 IMN, in 76 MS, and 73 clinically isolated syndrome (CIS) patients, as well as age/gender-matched healthy individuals. Anti-Gal and anti-Neu5Gc are significantly increased during IMN (p=0.02 and p<1.10-4 respectively), but not in acute CMV primo-infection. We show that, whereas there was no change in anti-Neu5Gc in MS/CIS, the two populations exhibit a significant decrease in anti-Gal (combined p=2.7.10-3), in contrast with patients with non-MS/CIS central nervous system pathologies. Since anti-Gal result from an immunization against α1,3 Gal, lacking in humans but produced in the gut, our data suggest that CIS and MS patients have an altered microbiota or an altered response to this microbiotic epitope.
Collapse
Affiliation(s)
- L Le Berre
- Centre de Recherche en Transplantation et Immunologie UMR 1064, INSERM, Université de Nantes, Nantes, France; Institut de Transplantation Urologie Néphrologie (ITUN), CHU Nantes, Nantes, France.
| | - J Rousse
- Centre de Recherche en Transplantation et Immunologie UMR 1064, INSERM, Université de Nantes, Nantes, France; Institut de Transplantation Urologie Néphrologie (ITUN), CHU Nantes, Nantes, France; Xenothera, Nantes, F44000 France
| | - P-A Gourraud
- Centre de Recherche en Transplantation et Immunologie UMR 1064, INSERM, Université de Nantes, Nantes, France; Institut de Transplantation Urologie Néphrologie (ITUN), CHU Nantes, Nantes, France
| | - B-M Imbert-Marcille
- EA 4271 - Immunovirologie et Polymorphisme Génétique, Centre Hospitalo-Universitaire de Nantes, Nantes, F44093, France
| | - A Salama
- Centre de Recherche en Transplantation et Immunologie UMR 1064, INSERM, Université de Nantes, Nantes, France; Institut de Transplantation Urologie Néphrologie (ITUN), CHU Nantes, Nantes, France; Xenothera, Nantes, F44000 France
| | - G Evanno
- Centre de Recherche en Transplantation et Immunologie UMR 1064, INSERM, Université de Nantes, Nantes, France; Institut de Transplantation Urologie Néphrologie (ITUN), CHU Nantes, Nantes, France; Xenothera, Nantes, F44000 France
| | - G Semana
- INSERM, UMR 917 - University of Rennes, Rennes, F35016 France; EFS Bretagne Rennes, F35016 France
| | - A Nicot
- Centre de Recherche en Transplantation et Immunologie UMR 1064, INSERM, Université de Nantes, Nantes, France; Institut de Transplantation Urologie Néphrologie (ITUN), CHU Nantes, Nantes, France
| | - E Dugast
- Centre de Recherche en Transplantation et Immunologie UMR 1064, INSERM, Université de Nantes, Nantes, France; Institut de Transplantation Urologie Néphrologie (ITUN), CHU Nantes, Nantes, France
| | - P Guérif
- Centre de Recherche en Transplantation et Immunologie UMR 1064, INSERM, Université de Nantes, Nantes, France; Institut de Transplantation Urologie Néphrologie (ITUN), CHU Nantes, Nantes, France
| | - C Adjaoud
- Centre Hospitalo-Universitaire de Nantes - Ecole Sages Femmes - Hopital Mere Enfant, Nantes, F44000 France
| | - T Freour
- Laboratoire de Biologie du Développement et de la Reproduction, CHU de Nantes, Nantes, F44093 France
| | - S Brouard
- Centre de Recherche en Transplantation et Immunologie UMR 1064, INSERM, Université de Nantes, Nantes, France; Institut de Transplantation Urologie Néphrologie (ITUN), CHU Nantes, Nantes, France
| | - F Agbalika
- Unit of Virology, Saint-Louis Hospital AP-HP, Université Paris-Diderot, Paris VII F75010, France
| | - R Marignier
- INSERM UMR 1028 - Centre de Recherche en Neurosciences de Lyon, Faculté de médecine - RTH Laënnec, Lyon, F69372 France
| | - D Brassat
- Department of Neurology - CHU Toulouse, Toulouse, F31300 France
| | - D-A Laplaud
- Centre de Recherche en Transplantation et Immunologie UMR 1064, INSERM, Université de Nantes, Nantes, France; Institut de Transplantation Urologie Néphrologie (ITUN), CHU Nantes, Nantes, France
| | - E Drouet
- Institute of Structural Biology, University Grenoble Alpes, UMR CNRS CEA UGA 5545 CEA, CNRS 38044 Grenoble, F38042 France
| | - V Van Pesch
- Unité de Neurochimie, Institute of Neuroscience, Université catholique de Louvain, Belgium
| | - J-P Soulillou
- Centre de Recherche en Transplantation et Immunologie UMR 1064, INSERM, Université de Nantes, Nantes, France; Institut de Transplantation Urologie Néphrologie (ITUN), CHU Nantes, Nantes, France
| |
Collapse
|
48
|
Elsokkary M, Elshourbagy M, Labib K, Mamdouh A, El-Shahawy Y, Nossair WS, Abd El Fattah O, Hemeda H, Sallam S, Khalaf WM, Ali M, Elsayed M, Kotb A, Abdelhadi R, Etman M, Abd El Aleem M, Samy M, Salama A, Abdelhaleem M, Abdelshafy A. Assessment of hysteroscopic role in management of women with recurrent pregnancy loss. J Matern Fetal Neonatal Med 2017; 31:1494-1504. [PMID: 28412850 DOI: 10.1080/14767058.2017.1319925] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
Abstract
OBJECTIVES To assess the hysteroscopic value in the management of intrauterine lesion in women with recurrent pregnancy loss. METHODS This study was done in Ain Shams Maternity Hospital after the approval of the research Ethics Committee, during the period between August 2014 and December 2015 where 200 nonpregnant women with a history of three or more consecutive unexplained first and second trimester miscarriages before 20 weeks were recruited from recurrent miscarriage clinic. A written informed consent was obtained from all women before participation. RESULTS This current study was conducted in Ain Shams University Maternity Hospital during the period between August 2014 to May 2015 a total of 200 women with history of recurrent miscarriage were included in the study. Regarding the results of this study the mean age was 30.5(5.7), the mean number of previous abortion 3(3-5) the mean number of the first trimesteric abortion was 2 with range (2-2) the mean number of second trimesteric abortion was 2 with range (1-2). In this study, 88% of patients were nullipara. It was also found that hysteroscopic findings were found in 58.5%. Uterine anomalies was present in 21%, including septate uterus and intrauterine adhesion (IUAs) were present in 12.5%. Endometrial polyps were present in 8.5%, bicornute uterus in 4.5%, unicornuate uterus in 4.5% while submucous myomas were present in 7.5%. It was found that 48.5% need hysteroscopic intervention including 21% need septectomy 12.5% need adhesiolysis, 6.5% need myomectomy while 8.5% need polypectomy. The study found that no statistically significant difference between patients with normal hysteroscopic finding and patients with abnormal hysteroscopic finding as regard age, time of previous abortion and number of previous abortion. But there was statistically significant difference as regard number of previous delivery and abnormal HSG. CONCLUSIONS It appears that hysteroscopy is a useful tool in the diagnosis and treatment of the causes of recurrent miscarriage that can be performed safely without anesthesia in most cases. The prevalence of uterine anomalies in patients with recurrent miscarriages is 54.5%, septate uterus is the most common anomaly and for this reason uterine anomalies should be systematically assessed in patients with recurrent miscarriage.
Collapse
Affiliation(s)
- M Elsokkary
- a Department of Obstetrics and Gynecology , Ain Shams University Maternity Hospital , Cairo , Egypt
| | - M Elshourbagy
- a Department of Obstetrics and Gynecology , Ain Shams University Maternity Hospital , Cairo , Egypt
| | - K Labib
- a Department of Obstetrics and Gynecology , Ain Shams University Maternity Hospital , Cairo , Egypt
| | - A Mamdouh
- a Department of Obstetrics and Gynecology , Ain Shams University Maternity Hospital , Cairo , Egypt
| | - Y El-Shahawy
- a Department of Obstetrics and Gynecology , Ain Shams University Maternity Hospital , Cairo , Egypt
| | - Wael S Nossair
- a Department of Obstetrics and Gynecology , Ain Shams University Maternity Hospital , Cairo , Egypt
| | - O Abd El Fattah
- a Department of Obstetrics and Gynecology , Ain Shams University Maternity Hospital , Cairo , Egypt
| | - H Hemeda
- a Department of Obstetrics and Gynecology , Ain Shams University Maternity Hospital , Cairo , Egypt
| | - S Sallam
- a Department of Obstetrics and Gynecology , Ain Shams University Maternity Hospital , Cairo , Egypt
| | - Waleed M Khalaf
- a Department of Obstetrics and Gynecology , Ain Shams University Maternity Hospital , Cairo , Egypt
| | - M Ali
- a Department of Obstetrics and Gynecology , Ain Shams University Maternity Hospital , Cairo , Egypt
| | - M Elsayed
- a Department of Obstetrics and Gynecology , Ain Shams University Maternity Hospital , Cairo , Egypt
| | - A Kotb
- a Department of Obstetrics and Gynecology , Ain Shams University Maternity Hospital , Cairo , Egypt
| | - R Abdelhadi
- a Department of Obstetrics and Gynecology , Ain Shams University Maternity Hospital , Cairo , Egypt
| | - M Etman
- a Department of Obstetrics and Gynecology , Ain Shams University Maternity Hospital , Cairo , Egypt
| | - M Abd El Aleem
- a Department of Obstetrics and Gynecology , Ain Shams University Maternity Hospital , Cairo , Egypt
| | - M Samy
- a Department of Obstetrics and Gynecology , Ain Shams University Maternity Hospital , Cairo , Egypt
| | - A Salama
- a Department of Obstetrics and Gynecology , Ain Shams University Maternity Hospital , Cairo , Egypt
| | - M Abdelhaleem
- a Department of Obstetrics and Gynecology , Ain Shams University Maternity Hospital , Cairo , Egypt
| | - A Abdelshafy
- a Department of Obstetrics and Gynecology , Ain Shams University Maternity Hospital , Cairo , Egypt
| |
Collapse
|
49
|
Abudunia AM, Marmouzi I, Faouzi M, Ramli Y, Taoufik J, El Madani N, Essassi E, Salama A, Khedid K, Ansar M, Ibrahimi A. Anticandidal, antibacterial, cytotoxic and antioxidant activities of Calendula arvensis flowers. J Mycol Med 2017; 27:90-97. [DOI: 10.1016/j.mycmed.2016.11.002] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/15/2016] [Revised: 10/29/2016] [Accepted: 11/20/2016] [Indexed: 10/20/2022]
|
50
|
Von Seth M, Hillered L, Otterbeck A, Hanslin K, Larsson A, Sjölin J, Lipcsey M, Cove ME, Chew NS, Vu LH, Lim RZ, Puthucheary Z, Hanslin K, Wilske F, Skorup P, Tano E, Sjölin J, Lipcsey M, Derese I, Thiessen S, Derde S, Dufour T, Pauwels L, Bekhuis Y, Van den Berghe G, Vanhorebeek I, Khan M, Dwivedi D, Zhou J, Prat A, Seidah NG, Liaw PC, Fox-Robichaud AE, Von Seth M, Skorup P, Hillered L, Larsson A, Sjölin J, Lipcsey M, Otterbeck A, Hanslin K, Lipcsey M, Larsson A, Von Seth M, Correa T, Pereira J, Takala J, Jakob S, Skorup P, Maudsdotter L, Tano E, Lipcsey M, Castegren M, Larsson A, Sjölin J, Xue M, Xu JY, Liu L, Huang YZ, Guo FM, Yang Y, Qiu HB, Kuzovlev A, Moroz V, Goloubev A, Myazin A, Chumachenko A, Pisarev V, Takeyama N, Tsuda M, Kanou H, Aoki R, Kajita Y, Hashiba M, Terashima T, Tomino A, Davies R, O’Dea KP, Soni S, Ward JK, O’Callaghan DJ, Takata M, Gordon AC, Wilson J, Zhao Y, Singer M, Spencer J, Shankar-Hari M, Genga KR, Lo C, Cirstea MS, Walley KR, Russell JA, Linder A, Boyd JH, Sedlag A, Riedel C, Georgieff M, Barth E, Debain A, Jonckheer J, Moeyersons W, Van zwam K, Puis L, Staessens K, Honoré PM, Spapen HD, De Waele E, de Garibay APR, Bracht H, Ende-Schneider B, Schreiber C, Kreymann B, Bini A, Votino E, Giuliano G, Steinberg I, Vetrugno L, Trunfio D, Sidoti A, Essig A, Brogi E, Forfori F, Conroy M, Marsh B, O’Flynn J, Henne-Bruns D, Gebhard F, Orend K, Halatsch M, Weiss M, Chase M, Freinkman E, Uber A, Liu X, Cocchi MN, Donnino MW, Peetermans M, Liesenborghs L, Claes J, Vanassche T, Hoylaerts M, Jacquemin M, Vanhoorelbeke K, De Meyer S, Verhamme P, Vögeli A, Ottiger M, Meier M, Steuer C, Bernasconi L, Huber A, Christ-Crain M, Henzen C, Hoess C, Thomann R, Zimmerli W, Müller B, Schütz P, Hoppensteadt D, Walborn A, Rondina M, Tsuruta K, Fareed J, Tachyla S, Ikeda T, Ono S, Ueno T, Suda S, Nagura T, Damiani E, Domizi R, Scorcella C, Tondi S, Pierantozzi S, Ciucani S, Mininno N, Adrario E, Pelaia P, Donati A, Andersen MS, Lu S, Lopez G, Lassen AT, Ghiran I, Shapiro NI, Trahtemberg U, Sviri S, Beil M, Agur Z, Van Heerden P, Jahaj E, Vassiliou A, Mastora Z, Orfanos SE, Kotanidou A, Wirz Y, Sager R, Amin D, Amin A, Haubitz S, Hausfater P, Huber A, Kutz A, Mueller B, Schuetz P, Sager RS, Wirz YW, Amin DA, Amin AA, Hausfater PH, Huber AH, Haubitz S, Kutz A, Mueller B, Schuetz P, Gottin L, Dell’amore C, Stringari G, Cogo G, Ceolagraziadei M, Sommavilla M, Soldani F, Polati E, Meier M, Baumgartner T, Zurauskaité G, Gupta S, Mueller B, Devendra A, Schuetz P, Mandaci D, Eren G, Ozturk F, Emir N, Hergunsel O, Azaiez S, Khedher S, Maaoui A, Salem M, Chernevskaya E, Beloborodova N, Bedova A, Sarshor YU, Pautova A, Gusarov V, Öveges N, László I, Forgács M, Kiss T, Hankovszky P, Palágyi P, Bebes A, Gubán B, Földesi I, Araczki Á, Telkes M, Ondrik Z, Helyes Z, Kemény Á, Molnár Z, Spanuth E, Ebelt H, Ivandic B, Thomae R, Werdan K, El-Shafie M, Taema K, El-Hallag M, Kandeel A, Tayeh O, Taema K, Eldesouky M, Omara A, Winkler MS, Holzmann M, Nierhaus A, Mudersbach E, Schwedhelm E, Daum G, Kluge S, Zoellner C, Greiwe G, Sawari H, Schwedhelm E, Nierhaus A, Kluge S, Kubitz J, Jung R, Daum G, Reichenspurner H, Zoellner C, Winkler MS, Groznik M, Ihan A, Andersen LW, Chase M, Holmberg MJ, Wulff A, Cocchi MN, Donnino MW, Balci C, Haliloglu M, Bilgili B, Bilgin H, Kasapoglu U, Sayan I, Süzer M, Mulazımoglu L, Cinel I, Patel V, Shah S, Parulekar P, Minton C, Patel J, Ejimofo C, Choi H, Costa R, Caruso P, Nassar P, Fu J, Jin J, Xu Y, Kong J, Wu D, Yaguchi A, Klonis A, Ganguly S, Kollef M, Burnham C, Fuller B, Mavrommati A, Chatzilia D, Salla E, Papadaki E, Kamariotis S, Christodoulatos S, Stylianakis A, Alamanos G, Simoes M, Trigo E, Silva N, Martins P, Pimentel J, Baily D, Curran LA, Ahmadnia E, Patel BV, Adukauskiene D, Cyziute J, Adukauskaite A, Pentiokiniene D, Righetti F, Colombaroli E, Castellano G, Wilske F, Skorup P, Lipcsey M, Hanslin K, Larsson A, Sjölin J, Man M, Shum HP, Chan YH, Chan KC, Yan WW, Lee RA, Lau SK, Dilokpattanamongkol P, Thirapakpoomanunt P, Anakkamaetee R, Montakantikul P, Tangsujaritvijit V, Sinha S, Pati J, Sahu S, Adukauskiene D, Valanciene D, Dambrauskiene A, Adukauskiene D, Valanciene D, Dambrauskiene A, Hernandez K, Lopez T, Saca D, Bello M, Mahmood W, Hamed K, Al Badi N, AlThawadi S, Al Hosaini S, Salahuddin N, Cilloniz CC, Ceccato AC, Bassi GLL, Ferrer MF, Gabarrus AG, Ranzani OR, Jose ASS, Vidal CGG, de la Bella Casa JPP, Blasi FB, Torres AT, Adukauskiene D, Ciginskiene A, Dambrauskiene A, Simoliuniene R, Giuliano G, Triunfio D, Sozio E, Taddei E, Brogi E, Sbrana F, Ripoli A, Bertolino G, Tascini C, Forfori F, Fleischmann C, Goldfarb D, Schlattmann P, Schlapbach L, Kissoon N, Baykara N, Akalin H, Arslantas MK, Gavrilovic SG, Vukoja MV, Hache MH, Kashyap RK, Dong YD, Gajic OG, Ranzani O, Shankar-Hari M, Harrison D, Rabello L, Rowan K, Salluh J, Soares M, Markota AM, Fluher JF, Kogler DK, Borovšak ZB, Sinkovic AS, László I, Öveges N, Forgács M, Kiss T, Hankovszky P, Palágyi P, Bebes A, Gubán B, Földesi I, Araczki Á, Telkes M, Ondrik Z, Helyes Z, Kemény Á, Molnár Z, Fareed J, Siddiqui Z, Aggarwal P, Iqbal O, Hoppensteadt D, Lewis M, Wasmund R, Abro S, Raghuvir S, Tsuruta K, Barie PS, Fineberg D, Radford A, Tsuruta K, Casazza A, Vilardo A, Bellazzi E, Boschi R, Ciprandi D, Gigliuto C, Preda R, Vanzino R, Vetere M, Carnevale L, Kyriazopoulou E, Pistiki A, Routsi C, Tsangaris I, Giamarellos-Bourboulis E, Kyriazopoulou E, Tsangaris I, Routsi C, Pnevmatikos I, Vlachogiannis G, Antoniadou E, Mandragos K, Armaganidis A, Giamarellos-Bourboulis E, Allan P, Oehmen R, Luo J, Ellis C, Latham P, Newman J, Pritchett C, Pandya D, Cripps A, Harris S, Jadav M, Langford R, Ko B, Park H, Beumer CM, Koch R, Beuningen DV, Oudelashof AM, Vd Veerdonk FL, Kolwijck E, VanderHoeven JG, Bergmans DC, Hoedemaekers C, Brandt JB, Golej J, Burda G, Mostafa G, Schneider A, Vargha R, Hermon M, Levin P, Broyer C, Assous M, Wiener-Well Y, Dahan M, Benenson S, Ben-Chetrit E, Faux A, Sherazi R, Sethi A, Saha S, Kiselevskiy M, Gromova E, Loginov S, Tchikileva I, Dolzhikova Y, Krotenko N, Vlasenko R, Anisimova N, Spadaro S, Fogagnolo A, Remelli F, Alvisi V, Romanello A, Marangoni E, Volta C, Degrassi A, Mearelli F, Casarsa C, Fiotti N, Biolo G, Cariqueo M, Luengo C, Galvez R, Romero C, Cornejo R, Llanos O, Estuardo N, Alarcon P, Magazi B, Khan S, Pasipanodya J, Eriksson M, Strandberg G, Lipsey M, Larsson A, Rajput Z, Hiscock F, Karadag T, Uwagwu J, Jain S, Molokhia A, Barrasa H, Soraluce A, Uson E, Rodriguez A, Isla A, Martin A, Fernández B, Fonseca F, Sánchez-Izquierdo JA, Maynar FJ, Kaffarnik M, Alraish R, Frey O, Roehr A, Stockmann M, Wicha S, Shortridge D, Castanheira M, Sader HS, Streit JM, Flamm RK, Falsetta K, Lam T, Reidt S, Jancik J, Kinoshita T, Yoshimura J, Yamakawa K, Fujimi S, Armaganidis A, Torres A, Zakynthinos S, Mandragos C, Giamarellos-Bourboulis E, Ramirez P, De la Torre-Prados M, Rodriguez A, Dale G, Wach A, Beni L, Hooftman L, Zwingelstein C, François B, Colin G, Dequin PF, Laterre PF, Perez A, Welte R, Lorenz I, Eller P, Joannidis M, Bellmann R, Lim S, Chana S, Patel S, Higuera J, Cabestrero D, Rey L, Narváez G, Blandino A, Aroca M, Saéz S, De Pablo R, Thiessen S, Vanhorebeek I, Derde S, Derese I, Dufour T, Albert CN, Langouche L, Goossens C, Peersman N, Vermeersch P, Vander Perre S, Holst J, Wouters P, Van den Berghe G, Liu X, Uber AU, Holmberg M, Konanki V, McNaughton M, Zhang J, Donnino MW, Demirkiran O, Byelyalov A, Luengo C, Guerrero J, Cariqueo M, Scorcella C, Domizi R, Damiani E, Tondi S, Pierantozzi S, Rossini N, Falanga U, Monaldi V, Adrario E, Pelaia P, Donati A, Cole O, Scawn N, Balciunas M, Blascovics I, Vuylsteke A, Salaunkey K, Omar A, Salama A, Allam M, Alkhulaifi A, Verstraete S, Vanhorebeek I, Van Puffelen E, Derese I, Ingels C, Verbruggen S, Wouters P, Joosten K, Hanot J, Guerra G, Vlasselaers D, Lin J, Van den Berghe G, Haines R, Zolfaghari P, Hewson R, Offiah C, Prowle J, Park H, Ko B, Buter H, Veenstra JA, Koopmans M, Boerma EC, Veenstra JA, Buter H, Koopmans M, Boerma EC, Taha A, Shafie A, Hallaj S, Gharaibeh D, Hon H, Bizrane M, El Khattate AA, Madani N, Abouqal R, Belayachi J, Kongpolprom N, Sanguanwong N, Sanaie S, Mahmoodpoor A, Hamishehkar H, Biderman P, Van Heerden P, Avitzur Y, Solomon S, Iakobishvili Z, Carmi U, Gorfil D, Singer P, Paisley C, Patrick-Heselton J, Mogk M, Humphreys J, Welters I, Pierantozzi S, Scorcella C, Domizi R, Damiani E, Tondi S, Casarotta E, Bolognini S, Adrario E, Pelaia P, Donati A, Holmberg MJ, Moskowitz A, Patel P, Grossestreuer A, Uber A, Andersen LW, Donnino MW, Malinverni S, Goedeme D, Mols P, Langlois PL, Szwec C, D’Aragon F, Heyland DK, Manzanares W, Manzanares W, Szwec C, Langlois P, Aramendi I, Heyland D, Stankovic N, Nadler J, Uber A, Holmberg M, Sanchez L, Wolfe R, Chase M, Donnino M, Cocchi M, Atalan HK, Gucyetmez B, Kavlak ME, Aslan S, Kargi A, Yazici S, Donmez R, Polat KY, Piechota M, Piechota A, Misztal M, Bernas S, Pietraszek-Grzywaczewska I, Saleh M, Hamdy A, Hamdy A, Elhallag M, Atar F, Kundakci A, Gedik E, Sahinturk H, Zeyneloglu P, Pirat A, Popescu M, Tomescu D, Van Gassel R, Baggerman M, Schaap F, Bol M, Nicolaes G, Beurskens D, Damink SO, Van de Poll M, Horibe M, Sasaki M, Sanui M, Iwasaki E, Sawano H, Goto T, Ikeura T, Hamada T, Oda T, Mayumi T, Kanai T, Kjøsen G, Horneland R, Rydenfelt K, Aandahl E, Tønnessen T, Haugaa H, Lockett P, Evans L, Somerset L, Ker-Reid F, Laver S, Courtney E, Dalton S, Georgiou A, Robinson K, Lam T, Haas B, Reidt S, Bartlett K, Jancik J, Bigwood M, Hanley R, Morgan P, Marouli D, Chatzimichali A, Kolyvaki S, Panteli A, Diamantaki E, Pediaditis E, Sirogianni P, Ginos P, Kondili E, Georgopoulos D, Askitopoulou H, Zampieri FG, Liborio AB, Besen BA, Cavalcanti AB, Dominedò C, Dell’Anna AM, Monayer A, Grieco DL, Barelli R, Cutuli SL, Maddalena AI, Picconi E, Sonnino C, Sandroni C, Antonelli M, Gucyetmez B, Atalan HK, Tuzuner F, Cakar N, Jacob M, Sahu S, Singh YP, Mehta Y, Yang KY, Kuo S, Rai V, Cheng T, Ertmer C, Czempik P, Hutchings S, Watts S, Wilson C, Burton C, Kirkman E, Drennan D, O’Prey A, MacKay A, Forrest R, Oglinda A, Ciobanu G, Casian M, Oglinda C, Lun CT, Yuen HJ, Ng G, Leung A, So SO, Chan HS, Lai KY, Sanguanwit P, Charoensuk W, Phakdeekitcharoen B, Batres-Baires G, Kammerzell I, Lahmer T, Mayr U, Schmid R, Huber W, Spanuth E, Bomberg H, Klingele M, Thomae R, Groesdonk H, Bernas S, Piechota M, Mirkiewicz K, Pérez AG, Silva J, Ramos A, Acharta F, Perezlindo M, Lovesio L, Antonelli PG, Dogliotti A, Lovesio C, Baron J, Schiefer J, Baron DM, Faybik P, Shum HP, Yan WW, Chan TM, Marouli D, Chatzimichali A, Kolyvaki S, Panteli A, Diamantaki E, Pediaditis E, Sirogianni P, Ginos P, Kondili E, Georgopoulos D, Askitopoulou H, Vicka V, Gineityte D, Ringaitiene D, Sipylaite J, Pekarskiene J, Beurskens DM, Van Smaalen TC, Hoogland P, Winkens B, Christiaans MH, Reutelingsperger CP, Van Heurn E, Nicolaes GA, Schmitt FS, Salgado ES, Friebe JF, Fleming TF, Zemva JZ, Schmoch TS, Uhle FU, Kihm LK, Morath CM, Nusshag CN, Zeier MZ, Bruckner TB, Mehrabi AM, Nawroth PN, Weigand MW, Hofer SH, Brenner TB, Fotopoulou G, Poularas I, Kokkoris S, Brountzos E, Zakynthinos S, Routsi C, Saleh M, Elghonemi M, Nilsson KF, Sandin J, Gustafsson L, Frithiof R, Skorniakov I, Varaksin A, Vikulova D, Shaikh O, Whiteley C, Ostermann M, Di Lascio G, Anicetti L, Bonizzoli M, Fulceri G, Migliaccio ML, Sentina P, Cozzolino M, Peris A, Khadzhynov D, Halleck F, Staeck O, Lehner L, Budde K, Slowinski T, Slowinski T, Kindgen-Milles D, Khadzhynov D, Huysmans N, Laenen MV, Helmschrodt A, Boer W. 37th International Symposium on Intensive Care and Emergency Medicine (part 3 of 3). Crit Care 2017. [PMCID: PMC5374592 DOI: 10.1186/s13054-017-1629-x] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022] Open
|